Additional Ukraine Supplemental Appropriations Act, 2022
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
66pct
11d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Additional Ukraine Supplemental Appropriations Act, 2022 This act provides $40.1 billion in FY2022 emergency supplemental appropriations for activities to respond to Russia's invasion of Ukraine. The act provides appropriations to several federal departments and agencies, including the Department of Justice, the Department of Defense, the Nuclear Regulatory Commission, the Department of Health and Human Services, the Department of State, the U.S. Agency for International Development, the Department of Agriculture, and the Department of the Treasury. Among other things, the act provides appropriations for defense equipment, migration and refugee assistance, regulatory and technical support regarding nuclear power issues, emergency food assistance, economic assistance, and seizures of property related to the invasion.
Yes
709
No
101
Present
0
Not Voting
20
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (20)
Became Public Law No: 117-128.
Became Public Law No: 117-128.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Yea-Nay Vote. 86 - 11. Record Vote Number: 191.
SenatePassed/agreed to in Senate: Passed Senate without amendment by Yea-Nay Vote. 86 - 11. Record Vote Number: 191.
SenateMotion by Senator Schumer to commit to Senate Committee on Appropriations with instructions to report back forthwith with the following amendment (SA 5037) fell when cloture was invoked on the measure in Senate. (CR S2607)
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| #190 | senate | On the Cloture Motion | Cloture Motion Agreed to (86-11, 3/5 majority required) | May 19, 2022 |
| #191 | senate | On Passage of the Bill | Bill Passed (86-11) | May 19, 2022 |
| #178 | senate | On the Motion to Proceed | Motion to Proceed Agreed to (88-11) | May 17, 2022 |
| #177 | senate | On Cloture on the Motion to Proceed | Cloture on the Motion to Proceed Agreed to (81-11, 3/5 majority required) | May 16, 2022 |
| #145 | house | On Passage | Passed | May 10, 2022 |
2022 · second_quarter · Budget/Appropriations
S (not yet introduced)/HR 8236 - Department of Defense Appropriations Act, 2023, including issues related to aircraft, helicopters, technology programs, surface and subsurface programs, Army acquisition matters, rotary wing aircraft, electronic warfare, munitions, missile defense funding and policy, procurement, Research Development Test Evaluation (RDTE); S (not yet introduced)/HR 7900 - National Defense Authorization Act for Fiscal Year 2023, including issues related to Army acquisition matters, rotary wing aircraft, electronic warfare, munitions, missile defense funding and policy, procurement, RDTE, aircraft, helicopters, technology programs; S (not yet introduced)/HR 8262 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2023, House Report 117-400, including issues related to the US Forest Service, aviation service contracts, modernization; S (not yet introduced)/HR 8257 - Department of Homeland Security Appropriations Act, 2023, including issues related to aircraft, technology programs; S (not yet introduced)/HR 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023, including issues related to aircraft, technology programs, deep space exploration, science programs, space operations, weather observations and forecasting, space commercialization; HR 7691 - Additional Ukraine Supplemental Appropriations Act, 2022, including issues related to Army acquisition matters, rotary wing aircraft, electronic warfare, munitions, missile defense funding and policy
Client expense: $3,510,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, State, Dept of (DOS)
2022 · second_quarter · Foreign Relations
S 1260 - United States Innovation and Competition Act of 2021 (USICA). Support the inclusion of language defining coerced censorship. S RES 609 - World Press Freedom Day Resolution. Support a free press globally. S 3764 - Internet Freedom and Operations (INFO) Act. Support a free and open internet globally. HR 7691 - Additional Ukraine Supplemental Appropriations Act. Support relief for Ukraine, particularly Ukrainian writers, artists, and culture. HR 7276/S 4134 - Ukraine Invasion War Crimes Deterrence and Accountability Act. Support adding cultural destruction as a war crime.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Support H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021, a bill to provide for special enrollment periods during public health emergencies; Letter urging Congress to provide additional funds to the Provider Relief Fund and for vaccine distribution and administration, which will allow for continued support of hospitals' COVID-19-related lost revenues, as well as additional expenses incurred due to purchasing supplies and equipment, staffing, establishing emergency testing and vaccination centers and constructing and retrofitting facilities; Support H.R. 708 and S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, a bill to provide temporary licensing reciprocity for telehealth and interstate health care treatment; Support H.R. 1306 and S. 412, National Coronavirus Commission Act of 2021, a bill to establish the Commission on the Coronavirus Pandemic in the United States; Support S. 610/ H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, a bill to address behavioral health and well-being among health care professionals; Support S. 773 a bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program; Support S.834, Resident Physician Shortage Reduction Act of 2021, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions; Oppose H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act, a bill to direct the Secretary of Labor to issue an occupational safety and health standard that requires covered employers within the health care and social service industries to develop and implement a comprehensive workplace violence prevention plan and urge the Committee on Education and Labor not to report it favorably; Support S.924 and H.R. 2130, Rural America Health Corps Act, a bill to establish a demonstration program to provide payments on eligible loans for individuals who are eligible for the National Health Service Corps Loan Repayment Program; Discussions with ASPR about COVID-19 related medical supply and personnel shortages; Discussions with FEMA about COVID-19 public assistance funding policies; Letter asking Congress to consider an infrastructure proposal that you prioritize hospital and health system needs to ensure our nations health care system is well positioned to meet the opportunities and challenges that lie ahead; Support S.1512/H.R. 2903, CONNECT for Health Act of 2021, a bill to amend title XVIII of the Social Security Act to expand access to telehealth services; Support H.R. 2255/ S 1024, Healthcare Workforce Resilience Act, a bill to enhance our Nations nurse and physician workforce during the COVID-19 crisis by recapturing unused immigrant visas; Support S.1568, Technical Reset to Advance the Instruction of Nurses (TRAIN) Act, a bill to amend title XVIII of the Social Security Act to provide a waiver of the cap on annual payments for nursing and allied health education payments; Support H.R. 3203, a bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; Statement to Senate Committee on Homeland Security and Governmental Affairs hearing on "COVID-19 Part II: Evaluating the Medical Supply Chain and Pandemic Response Gaps" urges Congress to take steps to strengthen the nations medical supply chain; Statement to Senate Committee on Finance hearing on COVID-19 Health Care Flexibilities: Perspectives, Experiences, and Lessons Learned stating that these flexibilities can continue to drive significant improvements in patient care long after the public health emergency (PHE) ends and given the beneficial impact of those specific flexibilities urges Congress and the Administration to make them permanent. In addition, a second group of flexibilities will remain critically important for some time following the PHE and will require a carefully crafted phase-out plan to ensure enough time is provided for a necessary transition. Without action from Congress and the Administration prior to the termination of the PHE, we are concerned that much of the progress made because of the implementation of many of these flexibilities may be unnecessarily halted or even lost; Letter urges Senate HELP Committee to consider recommendations and prioritize programs that support the health care workforce needs of the country in the wake of the COVID-19 pandemic and into the future; Support H.R. 769/S. 1491, Rural Maternal and Obstetric Modernization of Services Act or the Rural MOMS Act, a bill to amend the Public Health Service Act to improve obstetric care in rural areas; Support for S.1675/ H.R. 4387, Maternal Health Quality Improvement Act, a bill to improve maternal health; Support 1438, Opioid Workforce Act of 2021, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the opioid crisis; Support HR 3441,Substance Use Disorder Workforce Act, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the substance use disorder crisis; Support S.1810 / H.R.3541, Conrad State 30 and Physician Access Reauthorization Act, a bill to provide incentives to physicians to practice in rural and medically underserved communities; Statement to the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights for the hearing on Antitrust Applied: Hospital Consolidation Concerns and Solutions expressing that integration helps to ensure every community, whether rural, urban or suburban, has access to the same high standard of affordable, evidenced based care; discussions to ensure that H.R. 2547s limits on unfair practice under FDCPA for debt collectors does not inappropriately interfere with or restrict the ability of hospitals to be able to obtain payment for care provided; Support for revising/repealing changes to the Rural Health Clinic (RHC) Program that reduced reimbursement for provider-based RHCs; Hill outreach expressing concerns with United Healths retroactive denial of coverage for emergency-level care in facilities; Hill outreach expressing concern about CMS mid-build audit denials; Senate outreach on prior authorization legislation; Urge support for legislation/administrative action to extend the deadline to use PRF money; Urged HRSA to ensure that the drug companies that denied 340B Statute appropriate discounts make the impacted hospitals whole for the benefit of the vulnerable communities they serve; Support S. 2304 Drug-Price Transparency for Competition Act of 2021 (DTC Act of 2021), a bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information; Support S.246/H.R.851 Future Advancement of Academic Nursing Act or the FAAN Act, a bill to amend the Public Health Service Act to authorize grants to support schools of nursing in program enhancement and infrastructure modernization, increasing the number of nursing faculty and students, and for other purposes; Support S. 1568/HR 4407Technical Reset to Advance the Instruction of Nurses Act or the TRAIN Act, a bill to amend title XVIII of the Social Security Act to provide a waiver of the cap on annual payments for nursing and allied health education payments; Comment letter to the Occupational Safety and Health Administration (OSHA) recommending the withdrawal of the COVID-19 Emergency Temporary Standard for occupational exposure to COVID-19; Meeting with Department of Labor staff to discuss our concerns about the OSHA COVID-19 Emergency Temporary Standard for occupational exposure to COVID-19; Discussion with ASPR staff overseeing the Strategic National Stockpile about their intent to procure supplies of surgical masks; Call with Senator Cassidys staff to discuss concerns about impact of FEMA COVID-19 funding of traveling nurse agencies on hospital nursing shortages; Oppose S 2428, False Claims Amendments Act of 2021A bill to amend title 31, United States Code, to modify False Claims Act procedures, and for other purposes; Discussions about Provider Relief Fund - reporting on past disbursements and urging HHS to disburse remaining PRF money; Discussions about the challenges that teaching hospitals have with training the physician workforce, residency caps that limit funding for training programs, a shortage of residents pursuing primary care specialties, a growing patient pool due to the newly insured and aging of the population; Discussions about the hospital and health system priorities for infrastructure and reconciliation bills; Letter urging Congress to maintain the current legal and regulatory framework for evaluating mergers and acquisitions; Hill outreach to discuss the benefits of health care integration; Hill outreach about the negative impact of potentially anticompetitive conduct by nurse-staffing agencies; Support HR 5035/ S 2982 Child Suicide Prevention and Lethal Means Safety Act, a bill to authorize the Secretary of Health and Human Services to award grants to establish or expand programs to implement evidence-aligned practices in health care settings for the purpose of reducing the suicide rates of covered individuals, and for other purposes; Support H.R.5376 Build Back Better Act, this bill provides funding, establishes programs, and otherwise modifies provisions relating to a broad array of areas, including education, labor, child care, health care, taxes, immigration, and the environment; Discussions with members of congress about the implementation of Rural Emergency Hospital payment designation; Discussions on the No Surprises Act Implementation (surprise billing) and urging federal regulators to restore the independence of the independent dispute resolution process in the No Surprises Act Part 2 regulations; Support HR 5699 Student Assisted Vaccination Effort (SAVE) Act, a bill to expand the definition of qualified persons for purposes of the Public Readiness and Emergency Preparedness Act to include health professional students; Support S 2873 Preventing and Addressing Trauma with Health Services Act (PATHS Act), a bill to require the Secretary of Health and Human Services to award grants to establish or expand programs and activities to increase access to high-quality culturally competent trauma support and mental health care; Letter urging HRSA to delay proposals to withdraw certain HPSAs; Support S 3497 and HR 6397, Medical Student Education Authorization Act of 2022, a bill to amend the Public Health Service Act to establish a grant program to award grants to public institutions of higher education located in a covered State; Support HR 6279 and S 3629, Opioid Treatment Access Act of 2022, a bill to authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency; Support HR 5703 and S 3677, Post-Disaster Mental Health Response Act, a bill to amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to authorize the President to provide professional counseling services to victims of emergencies declared under such Act; Submitted a statement on the hearing for Pandemic Profiteers: Legislation to Stop Corporate Price Gouging regarding concerns about anticompetitive conduct on the part of health care staffing agencies, some of which have been exploiting the severe shortage of health care providers during the COVID-19 pandemic; Submitted a statement on the hearing for Americas Mental Health Crisis and supports additional approaches to help ensure improved access to needed comprehensive, affordable and quality behavioral health services; Provide comments to the Affordability Subcommittee of the Healthy Future Task Force expressing our shared focus with Congress on providing relief from the pandemic, ensuring a smooth recovery and rebuilding a better health care system for the future, all while continuing to support efforts to promote greater affordability and value to patients and the health care system; Submitted statement on the hearing for Recruiting, Revitalizing & Diversifying: Examining the Health Care Workforce Shortage about the challenges ahead and the need to examine Americas health care workforce shortage. We must work together to solve these issues so that our nations hospitals and health systems can continue to care for the patients and communities they serve; Submitted statement on the hearing for Protecting Youth Mental Health: Part II - Identifying and Addressing Barriers to Care examines ways to protect the mental health of our nations youth; Submitted statement on the hearing for Exploring Pathways to Affordable, Universal Health Coverage Care expressing the need to build upon and improve our existing system to increase access to coverage of comprehensive health benefits; Submitted a letter to provide information regarding the challenges facing Americas health care workforce as the country enters the third year of the COVID-19 pandemic; Provided comments to the Modernization Subcommittee of the Healthy Future Task Force urging Congress to consider how to ensure the telehealth flexibilities could remain in place for patients and health care providers beyond the PHE; Support HR 7053 and S 3792, Hospital Inpatient Services Modernization Act, a bill to amend title XVIII of the Social Security Act to extend acute hospital care at home waiver flexibilities; Support resolution, H. Res. 909, Expressing support for healthcare personnel and condemning assaults on healthcare personnel as the U.S. healthcare system faces unprecedented staffing shortages and increased workplace-related stressors; Letter urges Congress to provide immediate additional support for hospitals and health systems serving their communities during this unprecedented public health crisis. While the support Congress has provided during the last two years of the COVID-19 pandemic has helped hospitals care for their patients and communities, there is still a significant need for financial support and relief as COVID-19 challenges persist; Support S 3904, Healthcare Cybersecurity Act of 2022, a bill to enhance the cybersecurity of the Healthcare and Public Health Sector; Letter urging OSHA to extend the comment deadline for the rule making on the occupational exposure to COVID-19 in healthcare settings by at least an additional 30 days, through May 23; Meeting with the Office of the Assistant Secretary of Health (OASH) at HHS to discuss the widespread blood shortages in the U.S. and next steps; Stakeholder calls with HHS ASPR regarding the distribution/administration of COVID-19 therapeutics; Discussions on S 571, Public Health Funding Prevents Pandemics Act, a bill to fully fund the Prevention and Public Health Fund and reaffirm the importance of prevention in the United States healthcare system; Regular calls with ASPR and other stakeholders participating in the Health Care and Public Health (HPH) Sector Joint Supply Chain Resilience Working Group (Joint SCRWG), a formal Working Group under the authority of the Critical Infrastructure Partnership Advisory Council (CIPAC) to support the Presidents vision for a resilient public health supply chain; Monthly calls with ASPRs Hospital Preparedness Program (HPP) to discuss updates on the hospital association COVID-19 funding program; Call with ASPR Healthcare and Public Health Government Coordinating Council leadership and other hospital associations to provide feedback on the COVID-19 hospital data guidance update; Provide comment letter to OSHA on the re-opening of comments on the Occupational Exposure to COVID-19 Rulemaking in which we urge OSHA not to finalize its rule for occupational exposure to COVID-19. In our comments, we indicate that we continue to oppose establishing new regulations that are not fully aligned with the Centers for Disease Control and Preventions evolving evidence-based guidance. With the constantly evolving, science-based CDC guidance and recommendations, CMS vaccination requirement and existing OSHA general standards, we strongly believe that an inconsistent and overly strict OSHA COVID-19 health care standard is not necessary, would cause confusion and will ultimately lower hospital employees morale and worsen unprecedented personnel shortages in hospitals. It is essential to a well-functioning health care system that only one set of science-based standards be applied to health care providers, and that these standards be aligned across federal agencies; Letter urging Congress to make the expanded tax credits permanent, ensuring millions of low- and middle-income families continue to have access to affordable coverage in 2023 and beyond; Express concerns with the letter to CMS from Congressman Murphy that makes a number of requests for data surrounding the COVID-19 add on payments for hospitals. We are concerned about the questions as they do not take into account the continued needs of the nations hospitals and health systems. Hospitals continue to face numerous challenges, including increased labor and supply costs and workforce shortages. These additional payments have helped to address some but not all of the high costs associated with COVID-19 patient care. The complexity of care is still higher than pre-pandemic levels as measured by length of stay, which further indicates that its still more resource intensive to treat COVID inpatients. In addition, the high costs associated personal protective equipment, isolation measures, and other additional resources are necessary when treating all patients, unless and until it is determined they do not have COVID-19; Submitted a letter to Ways and Means per their request for information on the health care industry and climate change. We support the sustainability efforts while acknowledging that for a variety of reasons, many hospitals and health systems face challenges and barriers to implementing this work, especially while responding to a pandemic; Letter urging HHS to maintain the COVID-19 public health emergency (PHE) until it is clear that the global pandemic has receded and the capabilities authorized by the PHE are no longer necessary. This will help prevent any future surges from threatening the health and safety of patients and the ability of health care professionals to care for them; Long COVID Best Clinical Practices Discussion with the White House Policy Advisor, Office of the COVID-19 Response; Submitted comment letter to the Federal Trade Commission outlining the impact pharmacy benefit managers (PBMs) practices have on the field. Specifically, urging the FTC to increase scrutiny on insured-mandated white bagging policies, as well as the impact of PBM-negotiated rebates and other business practices on the 340B drug discount pricing program and overall drug prices and drug price increases; Submit a comment letter to the Internal Revenue Service for their proposed rule amending how employer coverage affordability would be measured for family members of employees. We advocated for a fix to the current methodology for assessing affordability of employer coverage for family members, often referred to as the family glitch, which is estimated to affect about 5 million individuals. We commend the IRS on proposing to revise the regulation and improve access to health insurance coverage for millions of American families; Concerns S.4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022, a bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological product; Comment letter on CMS Radiation Oncology (RO) Model proposed rule. We strongly supports CMS efforts to transform the delivery of cancer care. We also support the original intent of the RO Model, which was to protect access to care by ensuring fair, predictable payment for radiation oncologists. However, this important goal of the original RO Model has been marred by the incorporation of significant payment cuts and substantial administrative burdens for those participating in this mandatory model. As such, the AHA supports CMSs proposal to delay the start date of the RO model from Jan. 1, 2023 to a date to be determined through future rulemaking; Support S. 4352,Travel Nursing Agency Transparency Study Act, a bill to require a study on the effects of travel nurse agencies on the health industry during the COVID-19 pandemic; Letter in response to CMS request for guidance on implementing the regulatory requirement for convening providers and facilities exchange information with co-providers and co-facilities to create a comprehensive good faith estimate as part of the implementation of the No Surprises Act. Due to the lack of currently available automated solutions, this process would require a significant manual effort by providers, which would undoubtedly result in the convening provider being unable to meet the short statutory timeframes for delivering good faith estimates to the patients and could also lead to inadvertent errors. AHA has requested an extension in enforcement direction until a technical solution has been identified and implemented; Support HR 7691, Safety From Violence for Healthcare Employees Act or the SAVE Act, a bill to protect hospital personnel from violence, and for other purposes; Letter requesting that HHS, HRSA, and OIG take immediate enforcement action against the now 17 companies that are refusing to honor their obligations under the 340B program; Letter sent to HHS Secretary to discuss how best to ensure prompt repayment to 340B hospitals without penalizing the rest of the hospital field after the U.S. Supreme Court unanimously agreed that HHS outpatient payment cuts to hospitals in the 340B Drug Pricing Program were unlawful. The Courts decision did not determine a remedy for the unlawful payment cuts, instead, it remanded the case to the lower courts to address the proper remedy; Support HR 7084/ S 3983, Protecting and Transforming Cyber Health Care Act of 2022 or the PATCH Act of 2022, a bill to amend the Federal Food, Drug, and Cosmetic Act to require, for purposes of ensuring cybersecurity, the inclusion in any premarket submission for a cyber device of information to demonstrate a reasonable assurance of safety and effectiveness throughout the lifecycle of the cyber device, and for other purposes; Submit Comment letter of support for CMS continued focus on strengthening health insurance coverage and ensuring ease of enrollment and limited gaps in coverage, including proposed updates to Medicare enrollment and eligibility rules; Submit letter for oversight hearing on Medicare Advantage (MA) plans expressing concerns about some MA plans inappropriate restrictions on beneficiary access to medically necessary care, including those highlighted in a recent report issued by the Department of Health and Human Services Office of Inspector General (HHS-OIG), and urge Congress to increase its oversight of these plans; Provided feedback on the Senate Finance Committees discussion draft addressing mental health care and telehealth. AHA supports allowing Medicare beneficiaries who seek treatment for mental health disorders to receive their care through audio-only services, removing the requirement for Medicare patients to receive an in-person visit prior to receiving mental health services through telehealth, and expanding beyond physicians and limited non-physician practitioners the types of providers who can deliver and bill for telehealth services; Support HR 8576/ S 4352 Travel Nursing Agency Transparency Study Act, a bill to require a study on the effects of travel nurse agencies on the health industry during the COVID-19 pandemic; Support HR 8806 Healthcare Cybersecurity Act of 2022, a bill to enhance the cybersecurity of the Healthcare and Public Health Sector; Submitted a statement for the record for the Senate Judiciary Subcommittee hearing on Flatlining Care: Why Immigrants Are Crucial to Bolstering Our Health Care Workforce. This hearing examines the importance of improving the immigration process in order to help alleviate Americas health care workforce shortage. We encourage Congress to help address domestic health care workforce shortage;
2022 · fourth_quarter · Health Issues
Issues regarding childrens health care coverage and access to care under Medicaid, CHIP, the Exchanges, and private insurance Issues related to implementation of aspects of childrens health coverage under Medicaid, CHIP, the Exchanges, and private insurance Issues regarding the implementation of the ACE Kids Act S.1544/H.R. 3089 - Accelerating Kids Access to Care Act H.R. 7076/S. 3864, the Supporting Childrens Mental Health Care Access Act H.R. 7236 Strengthen Kids Mental Health Now Act S. 4472 Health Care Capacity for Pediatric Mental Health Act Issues regarding childrens and mothers health specifically continuous eligibility for children in Medicaid and CHIP, CHIP permanency, 12-months postpartum coverage for mothers and Medicaid coverage for children leaving the justice system. H.R. 4934, the Childrens Mental Health Infrastructure Act, H.R. 4944, the Helping Kids Cope Act, S.1902, the Behavioral Health Crisis Services Expansion Act Issues regarding childrens mental health, the national emergency in childrens mental health, and the Surgeon General Advisory on youth mental health. Issue regarding Medicaid supplemental payments HR. 3753/S. 1962 - Parity Implementation Act S.2762/H.R. 5131, the Pediatric Access to Critical Healthcare (PATCH) Act, and issues regarding pediatric health care infrastructure and capacity Issues regarding the importance of Medicaid to military and veteran families FY 2022 and FY 2023 Senate and House Labor-HHS appropriations provisions - Children's Hospitals Graduate Medical Education (CHGME) program funding Issues regarding Children's Hospitals Graduate Medical Education (CHGME) program reauthorization appropriations Issues related to additional funding for CHGME Issues related to 340B Drug Pricing Program, prescription drug pricing, drug shortages, and pharmaceutical supply chain, including H.R. 4390, the PROTECT 340B Act of 2021 Issues related to Provider Relief Funding Issues related to pediatric nursing workforce Issues regarding the passage and implementation of COVID-19 relief packages, increased FMAP funding, and the impact of COVID-19 on childrens hospitals, the pediatric supply chain, and pediatric residency programs Issues regarding COVID-19 vaccination efforts for children Issues regarding surprise billing bad debt, and price transparency in health care H.R. 1397 - Telehealth Improvement for Kids Essential Services (TIKES) Act and broader telehealth policies Mental health funding provided in Consolidated Appropriations Act and ARPA Issues regarding the Public Health Emergency Issues regarding 340B drug program and other drug issues H.R. 7691, Safety from Violence for Healthcare Employees (SAVE) Act H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022 S.4170, The Mental Health Reform Reauthorization Act of 2022 Issues regarding infant formula shortage Issues regarding food security and nutrition Issues regarding drugs and medical device shortages Issues regarding climate change S. 4747, Investing in Kids Mental Health Now Act VALID Act Issues regarding the uptake of childhood vaccines Issues included in the FY2023 Omnibus bill
2022 · fourth_quarter · Foreign Relations
Freedom of expression and free flow of information Global trade issues Digital services taxes H.R.7691 - Additional Ukraine Supplemental Appropriations Act Ukraine Response
Client expense: $2,720,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Cloture invoked in Senate by Yea-Nay Vote. 86 - 11. Record Vote Number: 190. (CR S2607)
SenateConsidered by Senate. (consideration: CR S2599-2600, S2602-2604, S2606-2607)
Motion by Senator Schumer to commit to Senate Committee on Appropriations with instructions to report back forthwith with the following amendment (SA 5037) made in Senate. (text: CR S2534)
Cloture motion on the measure presented in Senate. (CR S2533-2534)
Measure laid before Senate by motion. (consideration: CR S2526-2528, S2531-2534)
Motion to proceed to consideration of measure agreed to in Senate by Yea-Nay Vote. 88 - 11. Record Vote Number: 178.
SenateMotion to proceed to measure considered in Senate. (CR S2526)
Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 81 - 11. Record Vote Number: 177. (CR S2515)
SenateMotion to proceed to measure considered in Senate. (CR S2507)
Cloture motion on the motion to proceed to the measure presented in Senate. (CR S2486)
Motion to proceed to consideration of measure made in Senate. (CR S2486)
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 368.
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. (Legislative Day May 10, 2022).
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 368 - 57 (Roll no. 145). (text: CR H4775-4778)
HousePassed/agreed to in House: On passage Passed by the Yeas and Nays: 368 - 57 (Roll no. 145).(text: CR H4775-4778)
HouseThe previous question was ordered pursuant to the rule.
DEBATE - The House proceeded with one hour of debate on H.R. 7691.
Rule provides for consideration of H.R. 903, H.R. 2499, H.R. 5129 and H.R. 7691. The resolution provides for consideration of H.R. 903, H.R. 2499, and H.R. 5129 under a structured rule. H.R. 7691 is considered under a closed rule. Bills considered under the rule are debatable for one hour. The rule provides that H. Res. 1096 is adopted and amends H. Res. 188 by striking May 13, 2022 and inserting June 10, 2022.
Considered under the provisions of rule H. Res. 1097. (consideration: CR H4775-4783)
Rule H. Res. 1097 passed House.
Rules Committee Resolution H. Res. 1097 Reported to House. Rule provides for consideration of H.R. 903, H.R. 2499, H.R. 5129 and H.R. 7691. The resolution provides for consideration of H.R. 903, H.R. 2499, and H.R. 5129 under a structured rule. H.R. 7691 is considered under a closed rule. Bills considered under the rule are debatable for one hour. The rule provides that H. Res. 1096 is adopted and amends H. Res. 188 by striking May 13, 2022 and inserting June 10, 2022.
Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| -- |
Client expense: $6,950,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), SENATE, White House Office
Client expense: $780,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Oceanic & Atmospheric Administration (NOAA), SENATE, Treasury, Dept of
2022 · fourth_quarter · Agriculture
H.R. 2617, Consolidated Appropriations Act, 2023, issues Related to the Federal Crop Insurance Program H.R. 5376, Build Back Better Act, including provisions dealing with climate change as it relates to agriculture H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022, monitored for potential changes regarding the Federal Crop Insurance Program H.R. 8239, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023, monitored for funding levels and potential changes to administration of the Federal Crop Insurance Program S. 1251, Growing Climate Solutions Act Issues in support of preserving the Federal Crop Insurance Program, including in the 2018 Farm Bill and the upcoming 2022 reauthorization, agricultural appropriations, the budget, and the Standard Reinsurance Agreement. Regulatory reform improvements. Stimulus bills in relation to disaster payments to farmers. Monitor proposals impacting federal crop insurance programs.
Client expense: $440,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Risk Management Agency, SENATE
2022 · fourth_quarter · Aerospace
H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900/S. 4543, National Defense Authorization Act for Fiscal Year 2023 Space Innovation; Facilitating Capabilities for In-Space Servicing,Assembly, and Manufacturing (87 Fed. Reg. 56,365-56,372, September 14, 2022) Notice of In-space Authorization and Supervision Policy Listening Sessions; Request for Comments (87 Fed. Reg. 62,845-62,846, October 17, 2022) Various issues relating to supply chain and defense industrial base; small business innovation research;
Client expense: $20,990,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Defense
H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900/S. 4543, National Defense Authorization Act for Fiscal Year 2023 H.R. 8470/S. 4588, Investing in American Defense Technologies Act of 2022 Proposed Rule, Defense Acquisition Regulations System, Department of Defense; Defense Federal Acquisition Regulation Supplement: Undefinitized Contract Actions (87 Fed. Reg. 65,507-65,509, October 28, 2022) Various issues relating to potential expansion of the Committee on Foreign Investment in the United States (CFIUS); Russian sovereign debt; amendments and potential amendments to the FY23 National Defense Authorization Act, related to potential debarment of federal contractors with certain Fair Labor Standards Act (FLSA) violations, to credit reporting, to printed circuit boards, to cybersecurity reporting, to the National Security Innovation and Industrial Base (NSIB), Software Bill of Materials, and to perfluoroalkyl and polyfluoroalkyl substances (PFAS); the defense industrial base; administrative challenges for the Defense Industrial Base; supply chain and the defense industrial base; small business innovation research; Defense Federal Acquisition Regulation Supplement (DFARS)
Client expense: $20,990,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), Natl Security Council (NSC), SENATE, State, Dept of (DOS)
2022 · fourth_quarter · Trade (domestic/foreign)
H.R. 1386, Country of Origin Labeling Requirement Act H.R. 2072, Uyghur Forced Labor Disclosure Act H.R. 2668, Consumer Protection and Recovery Act H.R. 2907, Global Investment in American Jobs Act of 2021 H.R. 3460, State Antitrust Enforcement Venue Act of 2021 H.R. 3816, American Choice and Innovation Online Act H.R. 3825, Ending Platform Monopolies Act H.R. 3826, Platform Competition and Opportunity Act of 2021 H.R. 3843, Merger Filing Fee Modernization Act of 2021 H.R. 3849, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS) Act of 2021 H.R. 4346, CHIPS and Science Act H.R. 4521, America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (America COMPETES) Act of 2022 H.R. 5376, Inflation Reduction Act H.R. 5502, Integrity, Notification, and Fairness in Online Retail Marketplaces for (INFORM) Consumers Act H.R. 5544, To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to the products of Kazakhstan H.R. 6121/. 1187, Eliminating Global Market Distortions to Protect American Jobs Act of 2021 H.R. 6171, CNL Update Act H.R. 6329/S. 1854, National Critical Capabilities Defense Act of 2021 H.R. 6412, Import Security and Fairness Act H.R. 7185, Federal Contracting for Peace and Security Act H.R. 7691/S. 4930, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900/S. 4543, National Defense Authorization Act for Fiscal Year 2023 H.R. 8906, To provide for retroactive application of Generalized System of Preferences for the period after December 31, 2020, and before September 1, 2022 H.R. 9083/S. 5161, Fair Tariff Act of 2022 H.R. 9243, Providing Appropriate Recognition and Treatment Needed to Enhance Relations with ASEAN Act H.Res. 1294/S.Res. 727, Expressing the sense of the House of Representatives that the United States should negotiate strong, inclusive, and forward-looking rules on digital trade and the digital economy with like-minded countries as part of its broader trade and economic strategy in order to ensure American values of democracy, rule of law, freedom of speech, human and worker rights, privacy, and a free and open internet are at the very core of digital governance H.Res. 1342, Reaffirming the importance of diplomacy and development in United States-African Union relations, promoting strategic partnerships and shared objectives between the United States and the African Union, and expressing strong support for the successful implementation of the African Continental Free Trade Area S. 746, Trade Security Act of 2021 S. 1187, Eliminating Global Market Distortions To Protect American Jobs Act of 2021 S. 1260, United States Innovation and Competition Act of 2021 S. 2378, Fair, Affordable, Innovative, and Resilient (FAIR) Transition and Competition Act S. 2934, Bicameral Congressional Trade Authority Act of 2022 S. 3586, Ocean Shipping Competition Reform Act of 2022 S. 3850, Securing America's Ports of Entry Act of 2022 S. 4355, Clean Competition Act S. 4428, Taiwan Policy Act of 2022 S. 4450, Securing Privileged Economic, Commercial, Investment, And Legal Rights to Ensure Longstanding Atlantic Trade and Investment Opportunities and Nurture Security, Happiness, Innovation, and Prosperity (SPECIAL RELATIONSHIP) Act S. 4495, Protecting Americans' Data From Foreign Surveillance Act of 2022 Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Unfair or Deceptive Fees Trade Regulation Rule Commission Matter No. R207011 (87 Fed. 215, Reg. 67413-67,424, November 8, 2022) Advance notice of proposed rulemaking; request for public comment. Trade Regulation Rule on the Use of Reviews and Endorsements AGENCY: Federal Trade Commission. (87 Fed. Reg. 67,424-67,430, November 8, 2022) Notice, International Trade Commission; USMCA Automotive Rules of Origin: Economic Impact and Operations, 2023 Report (87 Fed. Reg. 48,495-48,497, August 9, 2022) Various issues relating to implementation of U.S. - Mexico-Canada (USMCA) trade agreement; implementation and revisions to the United States-Mexico-Canada Agreement Implementation Act (P.L. 116-113); U.S.-Korea Free Trade Agreement (KORUS); U.S.-Korea digital trade and services; United States-Mexico-Canada (USMCA) Labor Council; Generalized System of Preferences (GSP) reauthorization; ratification of the Assignment of Receivables in International Trade Convention; reforms to export controls; implementation of the American Manufacturing Competitiveness Act of 2016 (P.L.114-159); implementation of the Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); implementation of the Uyghur Forced Labor Prevention Act (UFLPA) (P.L. 117-78); implementation of the Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act, (P.L. 117-167); Section 232 of the Trade Expansion Act of 1962 (P.L. 87-794); Section 301 of the Trade Act of 1974 (P.L. 93-618); implementation of the African Growth and Opportunity Act (P.L. 106-200); International Emergency Economic Powers Act (IEEPA), Title II of Pub.L. 95-223; reauthorization of the Customs-Trade Partnership Against Terrorism (CTPAT); negotiations on a U.S.- Kenya Free Trade Agreement; International Telecommunications Union; World Health Organization (WHO); WHO Pandemic Treaty; World Intellectual Property Organization (WIPO); World Trade Organization (WTO) negotiations and agreements; World Trade Organization; Reform of the WTO; WTO Trade-Related Intellectual Property Rights (TRIPS) waiver; implementation of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; Executive Order 14017, America's Supply Chains; Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; patent linkage and regulatory data protection; China's intellectual property regime industrial policies and cyber security; implementation of the U.S.- China economic and trade agreement; IP issues relating to trade secret theft; IP issues relating to internet counterfeiting and piracy; IP issues relating to Australia, Brazil, Canada, China, India, Japan, Mexico, South Africa, and Europe; IP issues relating to Asia-Pacific Economic Cooperation Forum; U.S. economic and commercial relations with key trading partners across the globe; U.S. sanctions on Russia including those related to Russias threats to and invasion of Ukraine; U.S. sanctions on Turkey; U.S.-EU negotiations on a legal data transfer mechanism; U.S.-U.K. trade agreement; U.S.-EU energy and sustainability cooperation; U.S.-Taiwan Initiative on 21st-Century Trade; United States-India Trade Policy Forum; EU and international tax policy including digital tax proposals; U.S.-EU Trade & Technology Council; EU-U.S. Joint Technology Competition Policy Dialogue; EU Digital Markets Act; EU Digital Services Act; EU Data Act; EU Carbon Border Adjustment Mechanism; Indias Information Communications Technology (ICT) Tariffs; Federal Trade Commission statutory authority under Section 19 of the Federal Trade Commission Act of 1914; modernizing the Committee on Foreign Investment in the United States (CFIUS); efforts to implement an outbound investment screening mechanism; efforts related to boosting trade relations with the Latin American region; Export-Import Bank (Ex-Im Bank); trade policy consideration with regard to cross-border data flows and issues of forced localization; tax treaties with Chile and Poland; international affairs budget; international trade and regulatory practices impacting digital goods and services; international artificial intelligence policy; international 5G policy; international cybersecurity policy; international policies related to content moderation and intermediary liability; advancing international regulatory cooperation; steel and aluminum tariffs; trade policy concerns regarding customs duties on electronic transmissions; trade negotiations and trade priorities between the U.S. and the European Union; trade negotiations and trade priorities between the U.S. and the United Kingdom; trade negotiations and trade priorities between the U.S. and Japan; trade negotiations and trade priorities between the U.S. and China; proposed rules implementing Executive Order 13873, Securing the Information and Communications Technology and Services Supply Chain; implementation of the United States-Mexico-Canada trade agreement (USMCA), including plastics toxicity under the Canadian Environmental Protection Act; U.S.-Brazil trade; Pacific Digital Trade Agreements; U.S. Chile Tax Treaty, Convention for the Avoidance of Double Taxation and the Prevention Of Fiscal Evasion With Respect to Taxes on Income and Capital; U.S. Trade Representative on initiation of section 301 investigation of Frances digital services tax; ratification of the Kigali Amendment to the Montreal Protocol; efforts to pass the Miscellaneous Tariff bill; reauthorization of Trade Promotion Authority (TPA); efforts to provide financial support, trade facilitation, and infrastructure support to the African Continental Free Trade Area (AfCFTA); Russian sovereign debt; Commercial Service Office in Bangladesh; Indo-Pacific Economic Framework and digital trade issues associated with it; port negotiations; recommendations for Export Controls Cooperation at the U.S.-EU Trade and Technology Council; small business innovation research; supply chain and defense industrial base issues; printed circuit boards; 21st Century customs framework
Client expense: $20,990,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
2022 · fourth_quarter · Budget/Appropriations
Issues related to gender-based violence; FY23 SFOPS Appropriations; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · fourth_quarter · Foreign Relations
S. 3522 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022; H.R. 6930/S. 3838 - Asset Seizure for Ukraine Reconstruction Act; H.R. 7276 - Ukraine Invasion War Crimes Deterrence and Accountability Act; H.R. 6891 - Isolate Russian Government Officials Act of 2022; H.R. 7611 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 8144 - Ukrainian Fighter Pilots Act; S. Res. 713/H. Res. 1205 - Recognizing Russian actions in Ukraine as a genocide; H.R. 7429 - Russian Digital Asset Sanctions Compliance Act of 2022; and H.R. 8156 - Oligarch Assets for Ukrainian Victory Act of 2022; H.R. 8465 - Euro-Atlantic Solidarity and Major Democratic Ally Act of 2022; H.R. 5868 - Stop Military Selective Service Registration Act; H.R. 8532 - Atrocity Crimes, Relief and Accountability Act (ACRA Act); S. 4848/H.R. 8568 - Russia is a State Sponsor of Terrorism Act; S. 5164/H.R. 9381 - Holding Accountable Russian Mercenaries Act (HARM Act); S. 4937/H.R. 9059 - Non-Recognition of Russian Annexation of Ukrainian Territory Act; H.R. 7081 - Ukraine Comprehensive Debt Payment Relief Act of 2022; H.R.7066 - Russia and Belarus Financial Sanctions Act of 2022; H.R. 3344/S. 2876 - Transatlantic Telecommunications Security Act; S. 4509/H.R. 9511 - Black Sea Security Act of 2022; S. 4620 - Countering Communist Chinas Financing of Russias War on Ukraine Act; S. 4731 - Securing Allies Food in Emergencies Act (SAFE Act); S. 5010 - Ensuring Ukrainian Sovereignty Act; Issues related to humanitarian aid, sanctions, military aid, refugee processing.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
2022 · fourth_quarter · Budget/Appropriations
H.R. 2617 - FY2023 Consolidated Appropriations Act H.R. 8282/S. 4662 - State Department, Foreign Operations and Related Programs Appropriations Act, 2023 H.R. 5305 - FY2022 Extending Funding and Emergency Assistance Act H.R. 6119 - Further Extending Government Funding Act H.R. 8236 - Department of Defense Appropriations Act, 2023 H. R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 5376 - Inflation Reduction Act H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. S. 4678 Homeland Security Appropriations Act, 2023 Unnumbered Senate bill - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 S. 4662- State Department, Foreign Operations and Related Programs Act. 2023 S. 4659 - Labor, Health and Human Services Appropriations Act, 2023.
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Support H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021, a bill to provide for special enrollment periods during public health emergencies; Letter urging Congress to provide additional funds to the Provider Relief Fund and for vaccine distribution and administration, which will allow for continued support of hospitals' COVID-19-related lost revenues, as well as additional expenses incurred due to purchasing supplies and equipment, staffing, establishing emergency testing and vaccination centers and constructing and retrofitting facilities; Support H.R. 708 and S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, a bill to provide temporary licensing reciprocity for telehealth and interstate health care treatment; Support H.R. 1306 and S. 412, National Coronavirus Commission Act of 2021, a bill to establish the Commission on the Coronavirus Pandemic in the United States; Support S. 610/ H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, a bill to address behavioral health and well-being among health care professionals; Support S. 773 a bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program; Support S.834, Resident Physician Shortage Reduction Act of 2021, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions; Oppose H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act, a bill to direct the Secretary of Labor to issue an occupational safety and health standard that requires covered employers within the health care and social service industries to develop and implement a comprehensive workplace violence prevention plan and urge the Committee on Education and Labor not to report it favorably; Support S.924 and H.R. 2130, Rural America Health Corps Act, a bill to establish a demonstration program to provide payments on eligible loans for individuals who are eligible for the National Health Service Corps Loan Repayment Program; Discussions with ASPR about COVID-19 related medical supply and personnel shortages; Discussions with FEMA about COVID-19 public assistance funding policies; Letter asking Congress to consider an infrastructure proposal that you prioritize hospital and health system needs to ensure our nations health care system is well positioned to meet the opportunities and challenges that lie ahead; Support S.1512/H.R. 2903, CONNECT for Health Act of 2021, a bill to amend title XVIII of the Social Security Act to expand access to telehealth services; Support H.R. 2255/ S 1024, Healthcare Workforce Resilience Act, a bill to enhance our Nations nurse and physician workforce during the COVID-19 crisis by recapturing unused immigrant visas; Support S.1568, Technical Reset to Advance the Instruction of Nurses (TRAIN) Act, a bill to amend title XVIII of the Social Security Act to provide a waiver of the cap on annual payments for nursing and allied health education payments; Support H.R. 3203, a bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; Statement to Senate Committee on Homeland Security and Governmental Affairs hearing on "COVID-19 Part II: Evaluating the Medical Supply Chain and Pandemic Response Gaps" urges Congress to take steps to strengthen the nations medical supply chain; Statement to Senate Committee on Finance hearing on COVID-19 Health Care Flexibilities: Perspectives, Experiences, and Lessons Learned stating that these flexibilities can continue to drive significant improvements in patient care long after the public health emergency (PHE) ends and given the beneficial impact of those specific flexibilities urges Congress and the Administration to make them permanent. In addition, a second group of flexibilities will remain critically important for some time following the PHE and will require a carefully crafted phase-out plan to ensure enough time is provided for a necessary transition. Without action from Congress and the Administration prior to the termination of the PHE, we are concerned that much of the progress made because of the implementation of many of these flexibilities may be unnecessarily halted or even lost; Letter urges Senate HELP Committee to consider recommendations and prioritize programs that support the health care workforce needs of the country in the wake of the COVID-19 pandemic and into the future; Support H.R. 769/S. 1491, Rural Maternal and Obstetric Modernization of Services Act or the Rural MOMS Act, a bill to amend the Public Health Service Act to improve obstetric care in rural areas; Support for S.1675/ H.R. 4387, Maternal Health Quality Improvement Act, a bill to improve maternal health; Support 1438, Opioid Workforce Act of 2021, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the opioid crisis; Support HR 3441,Substance Use Disorder Workforce Act, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the substance use disorder crisis; Support S.1810 / H.R.3541, Conrad State 30 and Physician Access Reauthorization Act, a bill to provide incentives to physicians to practice in rural and medically underserved communities; Statement to the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights for the hearing on Antitrust Applied: Hospital Consolidation Concerns and Solutions expressing that integration helps to ensure every community, whether rural, urban or suburban, has access to the same high standard of affordable, evidenced based care; discussions to ensure that H.R. 2547s limits on unfair practice under FDCPA for debt collectors does not inappropriately interfere with or restrict the ability of hospitals to be able to obtain payment for care provided; Support for revising/repealing changes to the Rural Health Clinic (RHC) Program that reduced reimbursement for provider-based RHCs; Hill outreach expressing concerns with United Healths retroactive denial of coverage for emergency-level care in facilities; Hill outreach expressing concern about CMS mid-build audit denials; Senate outreach on prior authorization legislation; Urge support for legislation/administrative action to extend the deadline to use PRF money; Urged HRSA to ensure that the drug companies that denied 340B Statute appropriate discounts make the impacted hospitals whole for the benefit of the vulnerable communities they serve; Support S. 2304 Drug-Price Transparency for Competition Act of 2021 (DTC Act of 2021), a bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information; Support S.246/H.R.851 Future Advancement of Academic Nursing Act or the FAAN Act, a bill to amend the Public Health Service Act to authorize grants to support schools of nursing in program enhancement and infrastructure modernization, increasing the number of nursing faculty and students, and for other purposes; Support S. 1568/HR 4407Technical Reset to Advance the Instruction of Nurses Act or the TRAIN Act, a bill to amend title XVIII of the Social Security Act to provide a waiver of the cap on annual payments for nursing and allied health education payments; Comment letter to the Occupational Safety and Health Administration (OSHA) recommending the withdrawal of the COVID-19 Emergency Temporary Standard for occupational exposure to COVID-19; Meeting with Department of Labor staff to discuss our concerns about the OSHA COVID-19 Emergency Temporary Standard for occupational exposure to COVID-19; Discussion with ASPR staff overseeing the Strategic National Stockpile about their intent to procure supplies of surgical masks; Call with Senator Cassidys staff to discuss concerns about impact of FEMA COVID-19 funding of traveling nurse agencies on hospital nursing shortages; Oppose S 2428, False Claims Amendments Act of 2021A bill to amend title 31, United States Code, to modify False Claims Act procedures, and for other purposes; Discussions about Provider Relief Fund - reporting on past disbursements and urging HHS to disburse remaining PRF money; Discussions about the challenges that teaching hospitals have with training the physician workforce, residency caps that limit funding for training programs, a shortage of residents pursuing primary care specialties, a growing patient pool due to the newly insured and aging of the population; Discussions about the hospital and health system priorities for infrastructure and reconciliation bills; Letter urging Congress to maintain the current legal and regulatory framework for evaluating mergers and acquisitions; Hill outreach to discuss the benefits of health care integration; Hill outreach about the negative impact of potentially anticompetitive conduct by nurse-staffing agencies; Support HR 5035/ S 2982 Child Suicide Prevention and Lethal Means Safety Act, a bill to authorize the Secretary of Health and Human Services to award grants to establish or expand programs to implement evidence-aligned practices in health care settings for the purpose of reducing the suicide rates of covered individuals, and for other purposes; Support H.R.5376 Build Back Better Act, this bill provides funding, establishes programs, and otherwise modifies provisions relating to a broad array of areas, including education, labor, child care, health care, taxes, immigration, and the environment; Discussions with members of congress about the implementation of Rural Emergency Hospital payment designation; Discussions on the No Surprises Act Implementation (surprise billing) and urging federal regulators to restore the independence of the independent dispute resolution process in the No Surprises Act Part 2 regulations; Support HR 5699 Student Assisted Vaccination Effort (SAVE) Act, a bill to expand the definition of qualified persons for purposes of the Public Readiness and Emergency Preparedness Act to include health professional students; Support S 2873 Preventing and Addressing Trauma with Health Services Act (PATHS Act), a bill to require the Secretary of Health and Human Services to award grants to establish or expand programs and activities to increase access to high-quality culturally competent trauma support and mental health care; Letter urging HRSA to delay proposals to withdraw certain HPSAs; Support S 3497 and HR 6397, Medical Student Education Authorization Act of 2022, a bill to amend the Public Health Service Act to establish a grant program to award grants to public institutions of higher education located in a covered State; Support HR 6279 and S 3629, Opioid Treatment Access Act of 2022, a bill to authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency; Support HR 5703 and S 3677, Post-Disaster Mental Health Response Act, a bill to amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to authorize the President to provide professional counseling services to victims of emergencies declared under such Act; Submitted a statement on the hearing for Pandemic Profiteers: Legislation to Stop Corporate Price Gouging regarding concerns about anticompetitive conduct on the part of health care staffing agencies, some of which have been exploiting the severe shortage of health care providers during the COVID-19 pandemic; Submitted a statement on the hearing for Americas Mental Health Crisis and supports additional approaches to help ensure improved access to needed comprehensive, affordable and quality behavioral health services; Provide comments to the Affordability Subcommittee of the Healthy Future Task Force expressing our shared focus with Congress on providing relief from the pandemic, ensuring a smooth recovery and rebuilding a better health care system for the future, all while continuing to support efforts to promote greater affordability and value to patients and the health care system; Submitted statement on the hearing for Recruiting, Revitalizing & Diversifying: Examining the Health Care Workforce Shortage about the challenges ahead and the need to examine Americas health care workforce shortage. We must work together to solve these issues so that our nations hospitals and health systems can continue to care for the patients and communities they serve; Submitted statement on the hearing for Protecting Youth Mental Health: Part II - Identifying and Addressing Barriers to Care examines ways to protect the mental health of our nations youth; Submitted statement on the hearing for Exploring Pathways to Affordable, Universal Health Coverage Care expressing the need to build upon and improve our existing system to increase access to coverage of comprehensive health benefits; Submitted a letter to provide information regarding the challenges facing Americas health care workforce as the country enters the third year of the COVID-19 pandemic; Provided comments to the Modernization Subcommittee of the Healthy Future Task Force urging Congress to consider how to ensure the telehealth flexibilities could remain in place for patients and health care providers beyond the PHE; Support HR 7053 and S 3792, Hospital Inpatient Services Modernization Act, a bill to amend title XVIII of the Social Security Act to extend acute hospital care at home waiver flexibilities; Support resolution, H. Res. 909, Expressing support for healthcare personnel and condemning assaults on healthcare personnel as the U.S. healthcare system faces unprecedented staffing shortages and increased workplace-related stressors; Letter urges Congress to provide immediate additional support for hospitals and health systems serving their communities during this unprecedented public health crisis. While the support Congress has provided during the last two years of the COVID-19 pandemic has helped hospitals care for their patients and communities, there is still a significant need for financial support and relief as COVID-19 challenges persist; Support S 3904, Healthcare Cybersecurity Act of 2022, a bill to enhance the cybersecurity of the Healthcare and Public Health Sector; Letter urging OSHA to extend the comment deadline for the rule making on the occupational exposure to COVID-19 in healthcare settings by at least an additional 30 days, through May 23; Meeting with the Office of the Assistant Secretary of Health (OASH) at HHS to discuss the widespread blood shortages in the U.S. and next steps; Stakeholder calls with HHS ASPR regarding the distribution/administration of COVID-19 therapeutics; Discussions on S 571, Public Health Funding Prevents Pandemics Act, a bill to fully fund the Prevention and Public Health Fund and reaffirm the importance of prevention in the United States healthcare system; Regular calls with ASPR and other stakeholders participating in the Health Care and Public Health (HPH) Sector Joint Supply Chain Resilience Working Group (Joint SCRWG), a formal Working Group under the authority of the Critical Infrastructure Partnership Advisory Council (CIPAC) to support the Presidents vision for a resilient public health supply chain; Monthly calls with ASPRs Hospital Preparedness Program (HPP) to discuss updates on the hospital association COVID-19 funding program; Call with ASPR Healthcare and Public Health Government Coordinating Council leadership and other hospital associations to provide feedback on the COVID-19 hospital data guidance update; Provide comment letter to OSHA on the re-opening of comments on the Occupational Exposure to COVID-19 Rulemaking in which we urge OSHA not to finalize its rule for occupational exposure to COVID-19. In our comments, we indicate that we continue to oppose establishing new regulations that are not fully aligned with the Centers for Disease Control and Preventions evolving evidence-based guidance. With the constantly evolving, science-based CDC guidance and recommendations, CMS vaccination requirement and existing OSHA general standards, we strongly believe that an inconsistent and overly strict OSHA COVID-19 health care standard is not necessary, would cause confusion and will ultimately lower hospital employees morale and worsen unprecedented personnel shortages in hospitals. It is essential to a well-functioning health care system that only one set of science-based standards be applied to health care providers, and that these standards be aligned across federal agencies; Letter urging Congress to make the expanded tax credits permanent, ensuring millions of low- and middle-income families continue to have access to affordable coverage in 2023 and beyond; Express concerns with the letter to CMS from Congressman Murphy that makes a number of requests for data surrounding the COVID-19 add on payments for hospitals. We are concerned about the questions as they do not take into account the continued needs of the nations hospitals and health systems. Hospitals continue to face numerous challenges, including increased labor and supply costs and workforce shortages. These additional payments have helped to address some but not all of the high costs associated with COVID-19 patient care. The complexity of care is still higher than pre-pandemic levels as measured by length of stay, which further indicates that its still more resource intensive to treat COVID inpatients. In addition, the high costs associated personal protective equipment, isolation measures, and other additional resources are necessary when treating all patients, unless and until it is determined they do not have COVID-19; Submitted a letter to Ways and Means per their request for information on the health care industry and climate change. We support the sustainability efforts while acknowledging that for a variety of reasons, many hospitals and health systems face challenges and barriers to implementing this work, especially while responding to a pandemic; Letter urging HHS to maintain the COVID-19 public health emergency (PHE) until it is clear that the global pandemic has receded and the capabilities authorized by the PHE are no longer necessary. This will help prevent any future surges from threatening the health and safety of patients and the ability of health care professionals to care for them; Long COVID Best Clinical Practices Discussion with the White House Policy Advisor, Office of the COVID-19 Response; Submitted comment letter to the Federal Trade Commission outlining the impact pharmacy benefit managers (PBMs) practices have on the field. Specifically, urging the FTC to increase scrutiny on insured-mandated white bagging policies, as well as the impact of PBM-negotiated rebates and other business practices on the 340B drug discount pricing program and overall drug prices and drug price increases; Submit a comment letter to the Internal Revenue Service for their proposed rule amending how employer coverage affordability would be measured for family members of employees. We advocated for a fix to the current methodology for assessing affordability of employer coverage for family members, often referred to as the family glitch, which is estimated to affect about 5 million individuals. We commend the IRS on proposing to revise the regulation and improve access to health insurance coverage for millions of American families; Concerns S.4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022, a bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological product; Comment letter on CMS Radiation Oncology (RO) Model proposed rule. We strongly supports CMS efforts to transform the delivery of cancer care. We also support the original intent of the RO Model, which was to protect access to care by ensuring fair, predictable payment for radiation oncologists. However, this important goal of the original RO Model has been marred by the incorporation of significant payment cuts and substantial administrative burdens for those participating in this mandatory model. As such, the AHA supports CMSs proposal to delay the start date of the RO model from Jan. 1, 2023 to a date to be determined through future rulemaking; Support S. 4352,Travel Nursing Agency Transparency Study Act, a bill to require a study on the effects of travel nurse agencies on the health industry during the COVID-19 pandemic; Letter in response to CMS request for guidance on implementing the regulatory requirement for convening providers and facilities exchange information with co-providers and co-facilities to create a comprehensive good faith estimate as part of the implementation of the No Surprises Act. Due to the lack of currently available automated solutions, this process would require a significant manual effort by providers, which would undoubtedly result in the convening provider being unable to meet the short statutory timeframes for delivering good faith estimates to the patients and could also lead to inadvertent errors. AHA has requested an extension in enforcement direction until a technical solution has been identified and implemented; Support HR 7691, Safety From Violence for Healthcare Employees Act or the SAVE Act, a bill to protect hospital personnel from violence, and for other purposes; Letter requesting that HHS, HRSA, and OIG take immediate enforcement action against the now 17 companies that are refusing to honor their obligations under the 340B program; Letter sent to HHS Secretary to discuss how best to ensure prompt repayment to 340B hospitals without penalizing the rest of the hospital field after the U.S. Supreme Court unanimously agreed that HHS outpatient payment cuts to hospitals in the 340B Drug Pricing Program were unlawful. The Courts decision did not determine a remedy for the unlawful payment cuts, instead, it remanded the case to the lower courts to address the proper remedy; Support HR 7084/ S 3983, Protecting and Transforming Cyber Health Care Act of 2022 or the PATCH Act of 2022, a bill to amend the Federal Food, Drug, and Cosmetic Act to require, for purposes of ensuring cybersecurity, the inclusion in any premarket submission for a cyber device of information to demonstrate a reasonable assurance of safety and effectiveness throughout the lifecycle of the cyber device, and for other purposes; Submit Comment letter of support for CMS continued focus on strengthening health insurance coverage and ensuring ease of enrollment and limited gaps in coverage, including proposed updates to Medicare enrollment and eligibility rules; Submit letter for oversight hearing on Medicare Advantage (MA) plans expressing concerns about some MA plans inappropriate restrictions on beneficiary access to medically necessary care, including those highlighted in a recent report issued by the Department of Health and Human Services Office of Inspector General (HHS-OIG), and urge Congress to increase its oversight of these plans; Provided feedback on the Senate Finance Committees discussion draft addressing mental health care and telehealth. AHA supports allowing Medicare beneficiaries who seek treatment for mental health disorders to receive their care through audio-only services, removing the requirement for Medicare patients to receive an in-person visit prior to receiving mental health services through telehealth, and expanding beyond physicians and limited non-physician practitioners the types of providers who can deliver and bill for telehealth services; Support HR 8576/ S 4352 Travel Nursing Agency Transparency Study Act, a bill to require a study on the effects of travel nurse agencies on the health industry during the COVID-19 pandemic; Support HR 8806 Healthcare Cybersecurity Act of 2022, a bill to enhance the cybersecurity of the Healthcare and Public Health Sector; Submitted a statement for the record for the Senate Judiciary Subcommittee hearing on Flatlining Care: Why Immigrants Are Crucial to Bolstering Our Health Care Workforce. This hearing examines the importance of improving the immigration process in order to help alleviate Americas health care workforce shortage. We encourage Congress to help address domestic health care workforce shortage.
Client expense: $5,120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), SENATE, White House Office
2022 · third_quarter · Agriculture
H.R. 5376, Build Back Better Act, including provisions dealing with climate change as it relates to agriculture H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022, monitored for potential changes regarding the Federal Crop Insurance Program H.R. 8239, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023, monitored for funding levels and potential changes to administration of the Federal Crop Insurance Program S. 1251, Growing Climate Solutions Act Issues in support of preserving the Federal Crop Insurance Program, including in the 2018 Farm Bill and the upcoming 2022 reauthorization, agricultural appropriations, the budget, and the Standard Reinsurance Agreement. Regulatory reform improvements. Stimulus bills in relation to disaster payments to farmers. Monitor proposals impacting federal crop insurance programs.
Client expense: $720,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Risk Management Agency, SENATE
2022 · second_quarter · Agriculture
H.R. 5376, Build Back Better Act, including provisions dealing with climate change as it relates to agriculture H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022, monitored for potential changes regarding the Federal Crop Insurance Program H.R. 8239, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023, monitored for funding levels and potential changes to administration of the Federal Crop Insurance Program S. 1251, Growing Climate Solutions Act Issues in support of preserving the Federal Crop Insurance Program, including in the 2018 Farm Bill and the upcoming 2022 reauthorization, agricultural appropriations, the budget, and the Standard Reinsurance Agreement. Regulatory reform improvements. Stimulus bills in relation to disaster payments to farmers. Monitor proposals impacting federal crop insurance programs.
Client expense: $470,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Risk Management Agency, SENATE
2022 · third_quarter · Health Issues
Issues regarding childrens health care coverage and access to care under Medicaid, CHIP, the Exchanges, and private insurance Issues related to implementation of aspects of childrens health coverage under Medicaid, CHIP, the Exchanges, and private insurance Issues regarding the implementation of the ACE Kids Act S.1544/H.R. 3089 - Accelerating Kids Access to Care Act H.R. 7076/S. 3864, the Supporting Childrens Mental Health Care Access Act H.R. 7236 Strengthen Kids Mental Health Now Act S. 4472 Health Care Capacity for Pediatric Mental Health Act Issues regarding childrens health included in Build Back Better Act/reconciliation H.R. 4934, the Childrens Mental Health Infrastructure Act, H.R. 4944, the Helping Kids Cope Act, S.1902, the Behavioral Health Crisis Services Expansion Act Issues regarding childrens mental health, the national emergency in childrens mental health, and the Surgeon General Advisory on youth mental health. Issue regarding Medicaid supplemental payments HR. 3753/S. 1962 - Parity Implementation Act S.2762/H.R. 5131, the Pediatric Access to Critical Healthcare (PATCH) Act, and issues regarding pediatric health care infrastructure and capacity Issues regarding the importance of Medicaid to military and veteran families FY 2022 and FY 2023 Senate and House Labor-HHS appropriations provisions - Children's Hospitals Graduate Medical Education (CHGME) program funding Issues regarding Children's Hospitals Graduate Medical Education (CHGME) program reauthorization appropriations Issues related to 340B Drug Pricing Program, prescription drug pricing, drug shortages, and pharmaceutical supply chain, including H.R. 4390, the PROTECT 340B Act of 2021 Issues related to Provider Relief Funding Issues related to pediatric workforce Issues regarding the passage and implementation of COVID-19 relief packages, increased FMAP funding, and the impact of COVID-19 on childrens hospitals, the pediatric supply chain, and pediatric residency programs Issues regarding COVID-19 vaccination efforts for children Issues regarding surprise billing bad debt, and price transparency in health care H.R. 1397 - Telehealth Improvement for Kids Essential Services (TIKES) Act and broader telehealth policies Mental health funding provided in Consolidated Appropriations Act and ARPA Issues regarding the Public Health Emergency Issues regarding 340B drug program and other drug issues H.R. 7691, Safety from Violence for Healthcare Employees (SAVE) Act H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022 S.4170, The Mental Health Reform Reauthorization Act of 2022 Issues regarding infant formula shortage Issues regarding food security and nutrition Issues regarding medical device shortages Issues regarding climate change S. 4747, Investing in Kids Mental Health Now Act
Client expense: $565,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Oceanic & Atmospheric Administration (NOAA), SENATE, Treasury, Dept of
2022 · third_quarter · Foreign Relations
Freedom of expression and free flow of information Global trade issues Digital services taxes H.R.7691 - Additional Ukraine Supplemental Appropriations Act Ukraine Response
Client expense: $2,470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Trade (domestic/foreign)
H.R. 1386, Country of Origin Labeling Requirement Act H.R. 2072, Uyghur Forced Labor Disclosure Act H.R. 2668, Consumer Protection and Recovery Act H.R. 2907, Global Investment in American Jobs Act of 2021 H.R. 3460, State Antitrust Enforcement Venue Act of 2021 H.R. 3524, Ensuring American Global Leadership and Engagement (EAGLE) Act H.R. 3816, American Choice and Innovation Online Act H.R. 3825, Ending Platform Monopolies Act H.R. 3826, Platform Competition and Opportunity Act of 2021 H.R. 3843, Merger Filing Fee Modernization Act of 2021 H.R. 3849, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS) Act of 2021 H.R. 4346, CHIPS and Science Act H.R. 4521, America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (America COMPETES) Act of 2022 H.R. 5502, Integrity, Notification, and Fairness in Online Retail Marketplaces for (INFORM) Consumers Act H.R. 5544, To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to the products of Kazakhstan H.R. 6121/. 1187, Eliminating Global Market Distortions to Protect American Jobs Act of 2021 H.R. 6329/S. 1854, National Critical Capabilities Defense Act of 2021 H.R. 6412, Import Security and Fairness Act H.R. 7185, Federal Contracting for Peace and Security Act H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 H.R. 8282/S. 4662, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2023 H.R. 8666/S. 2934, Bicameral Congressional Trade Authority Act of 2022 H.Res. 1294/S.Res. 727, Expressing the sense of the House of Representatives that the United States should negotiate strong, inclusive, and forward-looking rules on digital trade and the digital economy with like-minded countries as part of its broader trade and economic strategy in order to ensure American values of democracy, rule of law, freedom of speech, human and worker rights, privacy, and a free and open internet are at the very core of digital governance S. 746, Trade Security Act of 2021 S. 1260, United States Innovation and Competition Act of 2021 S. 2107, Facilitating American-Built Semiconductors (FABS) Act S. 2378, Fair, Affordable, Innovative, and Resilient (FAIR) Transition and Competition Act S. 2716, American Beef Labeling Act of 2021 S. 3586, Ocean Shipping Competition Reform Act of 2022 S. 3850, Securing America's Ports of Entry Act of 2022 S. 4428, Taiwan Policy Act of 2022 S. 4495, Protecting Americans' Data From Foreign Surveillance Act of 2022 Draft legislation titled Fair Tariff Act of 2022 Nomination of Grant Harris to be Assistant Secretary of Commerce for Industry and Analysis at the United States Department of Commerce Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Request for Comments, Office of the U.S. Trade Representative; Trade Strategy to Combat Forced Labor (87 Fed. Reg. 40,3323-40,333, July 6, 2022) Various issues relating to Trans-Pacific Partnership (TPP) Agreement; Transatlantic Trade and Investment Partnership (TTIP); U. S.- Mexico-Canada (USMCA) trade agreement; implementation and revisions to the United States-Mexico-Canada Agreement Implementation Act (P.L. 116-113); U.S.-Korea Free Trade Agreement (KORUS); U.S.-Korea digital trade and services; United States-Mexico-Canada (USMCA) Labor Council; Generalized System of Preferences (GSP) reauthorization; U.S.-Central Asia Trade and Investment Framework Agreement (TIFA); ratification of the Assignment of Receivables in International Trade Convention; implementation of Foreign Agents Registration Act (FARA) (P.L. 75-583); reforms to export controls; implementation of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, Title XVII, Foreign Investment Risk Review Modernization Act (P.L. 115-232); implementation of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 (P. L. 116-283); implementation of the American Manufacturing Competitiveness Act of 2016 (P.L.114-159); implementation of Countering Americas Adversaries Through Sanctions Act (CAATSA) (P.L. 115-44); implementation of the Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); implementation of the National Defense Authorization Act for Fiscal Year 2022 (P.L. 117-81); implementation of the Uyghur Forced Labor Prevention Act (UFLPA) (P.L. 117-78); implementation of the Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act, (P.L. 117-167); Section 232 of the Trade Expansion Act of 1962 (P.L. 87-794); Section 301 of the Trade Act of 1974 (P.L. 93-618); implementation of the African Growth and Opportunity Act (P.L. 106-200); International Emergency Economic Powers Act (IEEPA), Title II of Pub.L. 95-223; reauthorization of the Customs-Trade Partnership Against Terrorism (CTPAT); negotiations on a U.S.- Kenya Free Trade Agreement; efforts to provide financial support, trade facilitation, and infrastructure support to the African Continental Free Trade Area (AfCFTA); International Telecommunications Union; World Health Organization (WHO); WHO Pandemic Treaty; World Intellectual Property Organization (WIPO); World Trade Organization (WTO) negotiations and agreements; Reform of the WTO; WTO COVID-19 related Trade-Related Intellectual Property Rights (TRIPS) waiver proposal; implementation of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; Executive Order 14017, America's Supply Chains; Executive Order 14005, Ensuring the Future Is Made in All of America by All of America's Workers; Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; patent linkage and regulatory data protection; China's intellectual property regime industrial policies and cyber security; implementation of the U.S.- China economic and trade agreement; implementation of the U.S.- Japan trade agreement; IP issues relating to internet counterfeiting and piracy; IP issues relating to trade secret theft; IP issues relating to Australia, Brazil, Canada, China, India, Japan, Mexico, South Africa, and Europe; U.S.-Argentina economic and commercial relations; U.S.-Bangladesh economic and commercial relations; U.S.-Brazil economic and commercial relations; U.S.-Canada economic and commercial relations; U.S.-China economic and commercial relations; U.S.-Colombia economic and commercial relations; U.S.-Cuba economic and commercial relations; U.S.-Egypt economic and commercial relations; U.S.-Ghana economic and commercial relations; U.S.-India economic and commercial relations; U.S.-Indonesia economic and commercial relations; U.S.-Iraq economic and commercial relations; U.S.-Israel economic and commercial relations; U.S.-Japan economic and commercial relations; U.S.-Kazakhstan economic and commercial relations; U.S.-Korea economic and commercial relations; U.S.-Mexico economic and commercial relations; U.S.-Nigeria economic and commercial relations; U.S.-Pakistan economic and commercial relations; U.S.-Russia economic and commercial relations; U.S.-South East Asia economic and commercial relations; U.S.-Turkey economic and commercial relations; U.S.-Taiwan economic and commercial relations; U.S.-U.K. trade and regulatory relations; U.S.-Vietnam economic and commercial relations; U.S. trade relations with the Middle East and North Africa; U.S. trade relations with Africa; U.S. sanctions on Russia including those related to Russias threats to and invasion of Ukraine; U.S. sanctions on Turkey; U.S. sanctions on Burma; U.S. sanctions on Venezuela; U.S.-EU negotiations on a legal data transfer mechanism; U.S.-U.K. trade agreement; U.S.-EU trade agreement; U.S.-EU energy and sustainability cooperation; U.S.-Switzerland economic and commercial relations; EU and international tax policy including digital tax proposals; U.S.-EU Trade & Technology Council; EU-U.S. Joint Technology Competition Policy Dialogue; EU Digital Markets Act; EU Digital Services Act; EU Data Act; EU Carbon Border Adjustment Mechanism; Indias Information Communications Technology (ICT) Tariffs; Federal Trade Commission statutory authority under Section 19 of the Federal Trade Commission Act of 1914; modernizing the Committee on Foreign Investment in the United States (CFIUS); efforts to implement an outbound investment screening mechanism; Export-Import Bank (Ex-Im Bank); trade policy consideration with regard to cross-border data flows and issues of forced localization; tax treaties with Hungary, Poland, Chile; funding for the Multilateral Development Banks (MDBs), including the World Bank, the African Development Bank (AfDB), the Asian Development Bank (ADB), the Inter-American Development Bank (IDB), the European Bank for Reconstruction and Development (EBRD) and the International Monetary Fund (IMF); international affairs budget; transatlantic investment, trade and regulatory cooperation; international trade and regulatory practices impacting digital goods and services; international artificial intelligence policy; international 5G policy; international cybersecurity policy; international policies related to content moderation and intermediary liability; advancing international regulatory cooperation; steel and aluminum tariffs; trade policy concerns regarding customs duties on electronic transmissions; trade negotiations and trade priorities between the U.S. and the European Union; trade negotiations and trade priorities between the U.S. and the United Kingdom; trade negotiations and trade priorities between the U.S. and Japan; trade negotiations and trade priorities between the U.S. and China; proposed rules implementing Executive Order 13873, Securing the Information and Communications Technology and Services Supply Chain; suspension of Title III of the Cuban Liberty and Democratic Solidarity Act of 1996 (P.L. 104-114); implementation of the United States-Mexico-Canada trade agreement (USMCA), including plastics toxicity under the Canadian Environmental Protection Act; U.S.-Brazil Trade Agreement to update the 2011 Agreement on Trade and Economic Cooperation (ATEC); U.S.-Brazil trade; Pacific Digital Trade Agreements; U.S. Chile Tax Treaty, Convention for the Avoidance of Double Taxation and the Prevention Of Fiscal Evasion With Respect to Taxes on Income and Capital; ratification of the Biodiversity Convention; ratification of the Kigali Amendment to the Montreal Protocol; efforts to pass legislation to implement the Basel Convention and related instruments; efforts to pass the Miscellaneous Tariff bill; reauthorization of Trade Promotion Authority (TPA); efforts related to the development of an Indo-Pacific Economic Framework; Russian sovereign debt; Commercial Service Office in Bangladesh; Indo-Pacific Economic Framework; port negotiations; recommendations for Export Controls Cooperation at the U.S.-EU Trade and Technology Council; small business innovation research; Buy America provisions especially in infrastructure legislation; supply chain and defense industrial base issues; printed circuit boards
Client expense: $23,940,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
2022 · third_quarter · Defense
H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900/S. 4543, National Defense Authorization Act for Fiscal Year 2023 Various issues relating to potential expansion of the Committee on Foreign Investment in the United States (CFIUS); Russian sovereign debt; amendments and potential amendments to the FY23 National Defense Authorization Act, related to potential debarment of federal contractors with certain Fair Labor Standards Act (FLSA) violations, to credit reporting, to printed circuit boards, to cybersecurity reporting, to the National Security Innovation and Industrial Base (NSIB), and to perfluoroalkyl and polyfluoroalkyl substances (PFAS); the defense industrial base; supply chain and the defense industrial base; small business innovation research; Buy America provisions especially in infrastructure legislation;
Client expense: $23,940,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), Natl Security Council (NSC), SENATE, State, Dept of (DOS)
2022 · third_quarter · Foreign Relations
Issues related to gender-based violence; FY23 SFOPS Appropriations; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · third_quarter · Budget/Appropriations
Issues related to gender-based violence; FY23 SFOPS Appropriations; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · third_quarter · Budget/Appropriations
H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Foreign Relations
S. 3522 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022; H.R. 6930 - Asset Seizure for Ukraine Reconstruction Act; H.R. 7276 - Ukraine Invasion War Crimes Deterrence and Accountability Act; H.R. 6891 - Isolate Russian Government Officials Act of 2022; H.R. 7611 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 8144 - Ukrainian Fighter Pilots Act; H. Res. 1205 - Recognizing Russian actions in Ukraine as a genocide; H.R. 7429 - Russian Digital Asset Sanctions Compliance Act of 2022; and H.R. 8156 - Oligarch Assets for Ukrainian Victory Act of 2022; Issues related to humanitarian aid, sanctions, military aid, refugee processing.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
2022 · second_quarter · Foreign Relations
S. 3522 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022; H.R. 6930 - Asset Seizure for Ukraine Reconstruction Act; H.R. 7276 - Ukraine Invasion War Crimes Deterrence and Accountability Act; H.R. 6891 - Isolate Russian Government Officials Act of 2022; H.R. 7611 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 8144 - Ukrainian Fighter Pilots Act; H. Res. 1205 - Recognizing Russian actions in Ukraine as a genocide; H.R. 7429 - Russian Digital Asset Sanctions Compliance Act of 2022; and H.R. 8156 - Oligarch Assets for Ukrainian Victory Act of 2022; Issues related to humanitarian aid, sanctions, military aid, refugee processing.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
2022 · third_quarter · Budget/Appropriations
H.R. 8282 - State Department, Foreign Operations and Related Programs Appropriations Act, 2023 H.R. 5305 - FY2022 Extending Funding and Emergency Assistance Act H.R. 6119 - Further Extending Government Funding Act H.R. 8236 - Department of Defense Appropriations Act, 2023 H. R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 5376 - Inflation Reduction Act H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. S. 4678 Homeland Security Appropriations Act, 2023 Unnumbered Senate bill - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 Unnumbered Senate bill- State Department, Foreign Operations and Related Programs Act. 2023 S. 4659 - Labor, Health and Human Services Appropriations Act, 2023.
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
HR 3807 "Restaurant Revitalization Fund Replenishment Act of 2021," all provisions. HR 7691 "Additional Ukraine Supplemental Appropriations Act, 2022," all provisions. HR 7790 "Emergency Supplemental Funding Bill to Address Baby Formula Shortage," all provisions. S 4008 "Small Business COVID Relief Act of 2022," all provisions. Issues pertaining to the inclusion of poison pill riders in appropriations. Issues pertaining to the inclusion of limiting amendments for rules issues under the Biden Administration.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Support H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021, a bill to provide for special enrollment periods during public health emergencies; Letter urging Congress to provide additional funds to the Provider Relief Fund and for vaccine distribution and administration, which will allow for continued support of hospitals' COVID-19-related lost revenues, as well as additional expenses incurred due to purchasing supplies and equipment, staffing, establishing emergency testing and vaccination centers and constructing and retrofitting facilities; Support H.R. 708 and S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, a bill to provide temporary licensing reciprocity for telehealth and interstate health care treatment; Support H.R. 1306 and S. 412, National Coronavirus Commission Act of 2021, a bill to establish the Commission on the Coronavirus Pandemic in the United States; Support S. 610/ H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, a bill to address behavioral health and well-being among health care professionals; Support S. 773 a bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program; Support S.834, Resident Physician Shortage Reduction Act of 2021, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions; Oppose H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act, a bill to direct the Secretary of Labor to issue an occupational safety and health standard that requires covered employers within the health care and social service industries to develop and implement a comprehensive workplace violence prevention plan and urge the Committee on Education and Labor not to report it favorably; Support S.924 and H.R. 2130, Rural America Health Corps Act, a bill to establish a demonstration program to provide payments on eligible loans for individuals who are eligible for the National Health Service Corps Loan Repayment Program; Discussions with ASPR about COVID-19 related medical supply and personnel shortages; Discussions with FEMA about COVID-19 public assistance funding policies; Letter asking Congress to consider an infrastructure proposal that you prioritize hospital and health system needs to ensure our nations health care system is well positioned to meet the opportunities and challenges that lie ahead; Support S.1512/H.R. 2903, CONNECT for Health Act of 2021, a bill to amend title XVIII of the Social Security Act to expand access to telehealth services; Support H.R. 2255/ S 1024, Healthcare Workforce Resilience Act, a bill to enhance our Nations nurse and physician workforce during the COVID-19 crisis by recapturing unused immigrant visas; Support S.1568, Technical Reset to Advance the Instruction of Nurses (TRAIN) Act, a bill to amend title XVIII of the Social Security Act to provide a waiver of the cap on annual payments for nursing and allied health education payments; Support H.R. 3203, a bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; Statement to Senate Committee on Homeland Security and Governmental Affairs hearing on "COVID-19 Part II: Evaluating the Medical Supply Chain and Pandemic Response Gaps" urges Congress to take steps to strengthen the nations medical supply chain; Statement to Senate Committee on Finance hearing on COVID-19 Health Care Flexibilities: Perspectives, Experiences, and Lessons Learned stating that these flexibilities can continue to drive significant improvements in patient care long after the public health emergency (PHE) ends and given the beneficial impact of those specific flexibilities urges Congress and the Administration to make them permanent. In addition, a second group of flexibilities will remain critically important for some time following the PHE and will require a carefully crafted phase-out plan to ensure enough time is provided for a necessary transition. Without action from Congress and the Administration prior to the termination of the PHE, we are concerned that much of the progress made because of the implementation of many of these flexibilities may be unnecessarily halted or even lost; Letter urges Senate HELP Committee to consider recommendations and prioritize programs that support the health care workforce needs of the country in the wake of the COVID-19 pandemic and into the future; Support H.R. 769/S. 1491, Rural Maternal and Obstetric Modernization of Services Act or the Rural MOMS Act, a bill to amend the Public Health Service Act to improve obstetric care in rural areas; Support for S.1675/ H.R. 4387, Maternal Health Quality Improvement Act, a bill to improve maternal health; Support 1438, Opioid Workforce Act of 2021, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the opioid crisis; Support HR 3441,Substance Use Disorder Workforce Act, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the substance use disorder crisis; Support S.1810 / H.R.3541, Conrad State 30 and Physician Access Reauthorization Act, a bill to provide incentives to physicians to practice in rural and medically underserved communities; Statement to the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights for the hearing on Antitrust Applied: Hospital Consolidation Concerns and Solutions expressing that integration helps to ensure every community, whether rural, urban or suburban, has access to the same high standard of affordable, evidenced based care; discussions to ensure that H.R. 2547s limits on unfair practice under FDCPA for debt collectors does not inappropriately interfere with or restrict the ability of hospitals to be able to obtain payment for care provided; Support for revising/repealing changes to the Rural Health Clinic (RHC) Program that reduced reimbursement for provider-based RHCs; Hill outreach expressing concerns with United Healths retroactive denial of coverage for emergency-level care in facilities; Hill outreach expressing concern about CMS mid-build audit denials; Senate outreach on prior authorization legislation; Urge support for legislation/administrative action to extend the deadline to use PRF money; Urged HRSA to ensure that the drug companies that denied 340B Statute appropriate discounts make the impacted hospitals whole for the benefit of the vulnerable communities they serve; Support S. 2304 Drug-Price Transparency for Competition Act of 2021 (DTC Act of 2021), a bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information; Support S.246/H.R.851 Future Advancement of Academic Nursing Act or the FAAN Act, a bill to amend the Public Health Service Act to authorize grants to support schools of nursing in program enhancement and infrastructure modernization, increasing the number of nursing faculty and students, and for other purposes; Support S. 1568/HR 4407Technical Reset to Advance the Instruction of Nurses Act or the TRAIN Act, a bill to amend title XVIII of the Social Security Act to provide a waiver of the cap on annual payments for nursing and allied health education payments; Comment letter to the Occupational Safety and Health Administration (OSHA) recommending the withdrawal of the COVID-19 Emergency Temporary Standard for occupational exposure to COVID-19; Meeting with Department of Labor staff to discuss our concerns about the OSHA COVID-19 Emergency Temporary Standard for occupational exposure to COVID-19; Discussion with ASPR staff overseeing the Strategic National Stockpile about their intent to procure supplies of surgical masks; Call with Senator Cassidys staff to discuss concerns about impact of FEMA COVID-19 funding of traveling nurse agencies on hospital nursing shortages; Oppose S 2428, False Claims Amendments Act of 2021A bill to amend title 31, United States Code, to modify False Claims Act procedures, and for other purposes; Discussions about Provider Relief Fund - reporting on past disbursements and urging HHS to disburse remaining PRF money; Discussions about the challenges that teaching hospitals have with training the physician workforce, residency caps that limit funding for training programs, a shortage of residents pursuing primary care specialties, a growing patient pool due to the newly insured and aging of the population; Discussions about the hospital and health system priorities for infrastructure and reconciliation bills; Letter urging Congress to maintain the current legal and regulatory framework for evaluating mergers and acquisitions; Hill outreach to discuss the benefits of health care integration; Hill outreach about the negative impact of potentially anticompetitive conduct by nurse-staffing agencies; Support HR 5035/ S 2982 Child Suicide Prevention and Lethal Means Safety Act, a bill to authorize the Secretary of Health and Human Services to award grants to establish or expand programs to implement evidence-aligned practices in health care settings for the purpose of reducing the suicide rates of covered individuals, and for other purposes; Support H.R.5376 Build Back Better Act, this bill provides funding, establishes programs, and otherwise modifies provisions relating to a broad array of areas, including education, labor, child care, health care, taxes, immigration, and the environment; Discussions with members of congress about the implementation of Rural Emergency Hospital payment designation; Discussions on the No Surprises Act Implementation (surprise billing) and urging federal regulators to restore the independence of the independent dispute resolution process in the No Surprises Act Part 2 regulations; Support HR 5699 Student Assisted Vaccination Effort (SAVE) Act, a bill to expand the definition of qualified persons for purposes of the Public Readiness and Emergency Preparedness Act to include health professional students; Support S 2873 Preventing and Addressing Trauma with Health Services Act (PATHS Act), a bill to require the Secretary of Health and Human Services to award grants to establish or expand programs and activities to increase access to high-quality culturally competent trauma support and mental health care; Letter urging HRSA to delay proposals to withdraw certain HPSAs; Support S 3497 and HR 6397, Medical Student Education Authorization Act of 2022, a bill to amend the Public Health Service Act to establish a grant program to award grants to public institutions of higher education located in a covered State; Support HR 6279 and S 3629, Opioid Treatment Access Act of 2022, a bill to authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency; Support HR 5703 and S 3677, Post-Disaster Mental Health Response Act, a bill to amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to authorize the President to provide professional counseling services to victims of emergencies declared under such Act; Submitted a statement on the hearing for Pandemic Profiteers: Legislation to Stop Corporate Price Gouging regarding concerns about anticompetitive conduct on the part of health care staffing agencies, some of which have been exploiting the severe shortage of health care providers during the COVID-19 pandemic; Submitted a statement on the hearing for Americas Mental Health Crisis and supports additional approaches to help ensure improved access to needed comprehensive, affordable and quality behavioral health services; Provide comments to the Affordability Subcommittee of the Healthy Future Task Force expressing our shared focus with Congress on providing relief from the pandemic, ensuring a smooth recovery and rebuilding a better health care system for the future, all while continuing to support efforts to promote greater affordability and value to patients and the health care system; Submitted statement on the hearing for Recruiting, Revitalizing & Diversifying: Examining the Health Care Workforce Shortage about the challenges ahead and the need to examine Americas health care workforce shortage. We must work together to solve these issues so that our nations hospitals and health systems can continue to care for the patients and communities they serve; Submitted statement on the hearing for Protecting Youth Mental Health: Part II - Identifying and Addressing Barriers to Care examines ways to protect the mental health of our nations youth; Submitted statement on the hearing for Exploring Pathways to Affordable, Universal Health Coverage Care expressing the need to build upon and improve our existing system to increase access to coverage of comprehensive health benefits; Submitted a letter to provide information regarding the challenges facing Americas health care workforce as the country enters the third year of the COVID-19 pandemic; Provided comments to the Modernization Subcommittee of the Healthy Future Task Force urging Congress to consider how to ensure the telehealth flexibilities could remain in place for patients and health care providers beyond the PHE; Support HR 7053 and S 3792, Hospital Inpatient Services Modernization Act, a bill to amend title XVIII of the Social Security Act to extend acute hospital care at home waiver flexibilities; Support resolution, H. Res. 909, Expressing support for healthcare personnel and condemning assaults on healthcare personnel as the U.S. healthcare system faces unprecedented staffing shortages and increased workplace-related stressors; Letter urges Congress to provide immediate additional support for hospitals and health systems serving their communities during this unprecedented public health crisis. While the support Congress has provided during the last two years of the COVID-19 pandemic has helped hospitals care for their patients and communities, there is still a significant need for financial support and relief as COVID-19 challenges persist; Support S 3904, Healthcare Cybersecurity Act of 2022, a bill to enhance the cybersecurity of the Healthcare and Public Health Sector; Letter urging OSHA to extend the comment deadline for the rule making on the occupational exposure to COVID-19 in healthcare settings by at least an additional 30 days, through May 23; Meeting with the Office of the Assistant Secretary of Health (OASH) at HHS to discuss the widespread blood shortages in the U.S. and next steps; Stakeholder calls with HHS ASPR regarding the distribution/administration of COVID-19 therapeutics; Discussions on S 571, Public Health Funding Prevents Pandemics Act, a bill to fully fund the Prevention and Public Health Fund and reaffirm the importance of prevention in the United States healthcare system; Regular calls with ASPR and other stakeholders participating in the Health Care and Public Health (HPH) Sector Joint Supply Chain Resilience Working Group (Joint SCRWG), a formal Working Group under the authority of the Critical Infrastructure Partnership Advisory Council (CIPAC) to support the Presidents vision for a resilient public health supply chain; Monthly calls with ASPRs Hospital Preparedness Program (HPP) to discuss updates on the hospital association COVID-19 funding program; Call with ASPR Healthcare and Public Health Government Coordinating Council leadership and other hospital associations to provide feedback on the COVID-19 hospital data guidance update; Provide comment letter to OSHA on the re-opening of comments on the Occupational Exposure to COVID-19 Rulemaking in which we urge OSHA not to finalize its rule for occupational exposure to COVID-19. In our comments, we indicate that we continue to oppose establishing new regulations that are not fully aligned with the Centers for Disease Control and Preventions evolving evidence-based guidance. With the constantly evolving, science-based CDC guidance and recommendations, CMS vaccination requirement and existing OSHA general standards, we strongly believe that an inconsistent and overly strict OSHA COVID-19 health care standard is not necessary, would cause confusion and will ultimately lower hospital employees morale and worsen unprecedented personnel shortages in hospitals. It is essential to a well-functioning health care system that only one set of science-based standards be applied to health care providers, and that these standards be aligned across federal agencies; Letter urging Congress to make the expanded tax credits permanent, ensuring millions of low- and middle-income families continue to have access to affordable coverage in 2023 and beyond; Express concerns with the letter to CMS from Congressman Murphy that makes a number of requests for data surrounding the COVID-19 add on payments for hospitals. We are concerned about the questions as they do not take into account the continued needs of the nations hospitals and health systems. Hospitals continue to face numerous challenges, including increased labor and supply costs and workforce shortages. These additional payments have helped to address some but not all of the high costs associated with COVID-19 patient care. The complexity of care is still higher than pre-pandemic levels as measured by length of stay, which further indicates that its still more resource intensive to treat COVID inpatients. In addition, the high costs associated personal protective equipment, isolation measures, and other additional resources are necessary when treating all patients, unless and until it is determined they do not have COVID-19; Submitted a letter to Ways and Means per their request for information on the health care industry and climate change. We support the sustainability efforts while acknowledging that for a variety of reasons, many hospitals and health systems face challenges and barriers to implementing this work, especially while responding to a pandemic; Letter urging HHS to maintain the COVID-19 public health emergency (PHE) until it is clear that the global pandemic has receded and the capabilities authorized by the PHE are no longer necessary. This will help prevent any future surges from threatening the health and safety of patients and the ability of health care professionals to care for them; Long COVID Best Clinical Practices Discussion with the White House Policy Advisor, Office of the COVID-19 Response; Submitted comment letter to the Federal Trade Commission outlining the impact pharmacy benefit managers (PBMs) practices have on the field. Specifically, urging the FTC to increase scrutiny on insured-mandated white bagging policies, as well as the impact of PBM-negotiated rebates and other business practices on the 340B drug discount pricing program and overall drug prices and drug price increases; Submit a comment letter to the Internal Revenue Service for their proposed rule amending how employer coverage affordability would be measured for family members of employees. We advocated for a fix to the current methodology for assessing affordability of employer coverage for family members, often referred to as the family glitch, which is estimated to affect about 5 million individuals. We commend the IRS on proposing to revise the regulation and improve access to health insurance coverage for millions of American families; Concerns S.4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022, a bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological product; Comment letter on CMS Radiation Oncology (RO) Model proposed rule. We strongly supports CMS efforts to transform the delivery of cancer care. We also support the original intent of the RO Model, which was to protect access to care by ensuring fair, predictable payment for radiation oncologists. However, this important goal of the original RO Model has been marred by the incorporation of significant payment cuts and substantial administrative burdens for those participating in this mandatory model. As such, the AHA supports CMSs proposal to delay the start date of the RO model from Jan. 1, 2023 to a date to be determined through future rulemaking; Support S. 4352,Travel Nursing Agency Transparency Study Act, a bill to require a study on the effects of travel nurse agencies on the health industry during the COVID-19 pandemic; Letter in response to CMS request for guidance on implementing the regulatory requirement for convening providers and facilities exchange information with co-providers and co-facilities to create a comprehensive good faith estimate as part of the implementation of the No Surprises Act. Due to the lack of currently available automated solutions, this process would require a significant manual effort by providers, which would undoubtedly result in the convening provider being unable to meet the short statutory timeframes for delivering good faith estimates to the patients and could also lead to inadvertent errors. AHA has requested an extension in enforcement direction until a technical solution has been identified and implemented; Support HR 7691, Safety From Violence for Healthcare Employees Act or the SAVE Act, a bill to protect hospital personnel from violence, and for other purposes; Letter requesting that HHS, HRSA, and OIG take immediate enforcement action against the now 17 companies that are refusing to honor their obligations under the 340B program; Letter sent to HHS Secretary to discuss how best to ensure prompt repayment to 340B hospitals without penalizing the rest of the hospital field after the U.S. Supreme Court unanimously agreed that HHS outpatient payment cuts to hospitals in the 340B Drug Pricing Program were unlawful. The Courts decision did not determine a remedy for the unlawful payment cuts, instead, it remanded the case to the lower courts to address the proper remedy; Support HR 7084/ S 3983, Protecting and Transforming Cyber Health Care Act of 2022 or the PATCH Act of 2022, a bill to amend the Federal Food, Drug, and Cosmetic Act to require, for purposes of ensuring cybersecurity, the inclusion in any premarket submission for a cyber device of information to demonstrate a reasonable assurance of safety and effectiveness throughout the lifecycle of the cyber device, and for other purposes; Submit Comment letter of support for CMS continued focus on strengthening health insurance coverage and ensuring ease of enrollment and limited gaps in coverage, including proposed updates to Medicare enrollment and eligibility rules; Submit letter for oversight hearing on Medicare Advantage (MA) plans expressing concerns about some MA plans inappropriate restrictions on beneficiary access to medically necessary care, including those highlighted in a recent report issued by the Department of Health and Human Services Office of Inspector General (HHS-OIG), and urge Congress to increase its oversight of these plans.
Client expense: $4,580,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), SENATE, White House Office
2022 · second_quarter · Defense
H.R. 6329, National Critical Capabilities Defense Act of 2021, all provisions. H.R. 6443, Arm Taiwan Act of 2022, all provisions. H.R. 7855, Halting Academic Liaisons To (HALT) our Adversaries Act, all provisions. H.R. 7987, DEFEND Act of 2022, all provisions. H.R.7691, Additional Ukraine Supplemental Appropriations Act, 2022, all provisions. S. 1854, National Critical Capabilities Defense Act of 2021, all provisions. S. 3131, Arm Taiwan Act of 2021, all provisions. S. 4366, DEFEND Act of 2022, all provisions. S. 73, American Security Drone Act of 2021, all provisions. H.R. 7900, National Defense Authorization Act for Fiscal Year 2023, (issues related to Abraham Accords, Accelerating Arms Deliveries, Caesar Syria Civilian Protection Act, Chinas Global Shipping Networks, Chinese Military Companies Operations and Influence in the U.S., Chinese Military-Affiliated Universities, Counter-UAS System Capabilities, International and Multilateral Organizations, Iran in Latin America, Iran Sanctions, Iran Terrorism Accountability, IRGC Ownership, Missile Defense Cooperation in the Middle East, Money Laundering, Rare Earth Elements, Reauthorization of the SHIELDS Act, Russia in Latin America, Russia/Iran Sanctions Evasion, Russian Energy Dependency, Safeguarding U.S. Government-Funded Research, Terror Groups' Use of Human Shields, U.S. Defense Supply Chain, U.S. Military Exercises in the Indo-Pacific, U.S. Military Exercises in the Middle East, U.S. Policy on China, U.S. Policy on China-Russia Ties, U.S. Policy on Iran, U.S. Policy on Russia, U.S. Sanctions Policy, U.S. Security Cooperation and Assistance, U.S.-Israel Operations-Technology Working Group). S. 4543, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, (issues related to Abraham Accords, Accelerating Arms Deliveries, Caesar Syria Civilian Protection Act, Chinese Military Companies Operations and Influence in the U.S., Counter-UAS System Capabilities, International and Multilateral Organizations, Iran Sanctions, Iran Terrorism Accountability, IRGC Ownership, Missile Defense Cooperation in the Middle East, Money Laundering, National Guard International Partnerships, Rare Earth Elements, Russia/Iran Sanctions Evasion, U.S. Defense Supply Chain, U.S. Pacific Islands Strategy, U.S. Policy on Taiwan, U.S. Security Cooperation and Assistance). Issues related to Abraham Accords, Chinas Military Strategy and Capabilities, Chinese Influence Operations, Chinese Military Companies Operations and Influence in the U.S., Chinese Military-Civil Fusion Strategy, Implementation of the Sanctioning the Use of Civilians as Defenseless Shields Act, Irans Military Strategy and Capabilities, U.S. Arms Sales, U.S. Cybersecurity Strategy and Capabilities, U.S. Defense Industrial Base & Supply Chain, U.S. Policy on China, U.S. Policy on Iran, U.S. Policy on Israel, U.S. Policy on Lebanon, U.S. Policy on Russia, U.S. Policy on Taiwan, U.S. Policy on Turkey, U.S. Policy on Ukraine, U.S. Security Cooperation and Assistance, U.S. Strategy in the Indo-Pacific Region (no bill).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
H.R. 7900 - National Defense Authorization Act FY23 (Senate Bill Pending), H.R. 8236 Department of Defense Appropriations Act FY23, H.R. 4432/S.3023 - Department of Defense Appropriations Act FY22, H.R. 7691, the Additional Ukraine Supplemental Appropriations Act of 2022, and S. 4503 - Intelligence Authorization Act FY23; provisions relating to acquisition policy, aircraft propulsion, force protection, command and control, simulation and training, self-defense systems and decoys, missile defense, sensors and radars, missiles, munitions and artillery, advanced materials and advanced technology programs, thermal management research, novel power systems, naval shipbuilding and systems, system sustainment, avionics, and intelligence matters. H.R. 8294 - Transportation, Housing and Urban Development and Related Agencies Appropriations Act FY23; issues related to air traffic control modernization, satellite voice communications, FAA. H.R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act FY23; issues related to NOAA, NASA.
Client expense: $2,400,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Director of National Intelligence (ODNI), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), Natl Oceanic & Atmospheric Administration (NOAA), SENATE
2022 · second_quarter · Aerospace
H.R. 7900 - National Defense Authorization Act FY23, (Senate Bill Pending), H.R. 8236 - Department of Defense Appropriations Act FY23,and H.R. 7691, the Additional Ukraine Supplemental Appropriations Act of 2022, H.R. 8256 - Commerce, Justice, Science and Related Agencies Appropriations Act FY23, H.R. 8294 - Transportation, Housing and Urban Development and Related Agencies Appropriations Act FY23; provisions relating to acquisition policy, aircraft propulsion, force protection, command and control, simulation and training, self-defense systems and decoys, missile defense, sensors and radars, missiles, munitions and artillery, advanced materials and advanced technology programs, thermal management research, novel power systems, naval shipbuilding and systems, system sustainment, avionics, and intelligence matters; and general space priorities specific to NASA and NOAA.
Client expense: $2,400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Defense
H.R. 7900 -National Defense Authorization FY23 (Senate Bill Pending), H.R. 8236 - Department of Defense Appropriations Act FY23, H.R. 7691 - the Additional Ukraine Supplemental Appropriations Act of 2022; provisions relating to acquisition policy, aircraft propulsion, force protection, command and control, simulation and training, self-defense systems and decoys, missile defense, sensors and radars, missiles, munitions and artillery, advanced materials and advanced technology programs, thermal management research, novel power systems, naval shipbuilding and systems, system sustainment, avionics, and intelligence matters. Issues related to P.L. 115-254 - the FAA Reauthorization Act of 2018. Issues related to recovery funding for military engine defense industrial base.
Client expense: $2,400,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
House and Senate FY22 Agriculture Appropriations bills House and Senate FY22 State/Foreign Operations Appropriations bills House and Senate FY23 Agriculture Appropriations bills House and Senate FY23 State/Foreign Operations Appropriations bills H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: $80,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), President of the U.S., SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · second_quarter · Budget/Appropriations
H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
S (not yet introduced)/HR 8236 - Department of Defense Appropriations Act, 2023, including issues related to aircraft, helicopters, technology programs, surface and subsurface programs, Army acquisition matters, rotary wing aircraft, electronic warfare, munitions, missile defense funding and policy, procurement, Research Development Test Evaluation (RDTE); S (not yet introduced)/HR 7900 - National Defense Authorization Act for Fiscal Year 2023, including issues related to Army acquisition matters, rotary wing aircraft, electronic warfare, munitions, missile defense funding and policy, procurement, RDTE, aircraft, helicopters, technology programs; S (not yet introduced)/HR 8262 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2023, House Report 117-400, including issues related to the US Forest Service, aviation service contracts, modernization; S (not yet introduced)/HR 8257 - Department of Homeland Security Appropriations Act, 2023, including issues related to aircraft, technology programs; S (not yet introduced)/HR 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023, including issues related to aircraft, technology programs, deep space exploration, science programs, space operations, weather observations and forecasting, space commercialization; HR 7691 - Additional Ukraine Supplemental Appropriations Act, 2022, including issues related to Army acquisition matters, rotary wing aircraft, electronic warfare, munitions, missile defense funding and policy
Client expense: $3,410,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, State, Dept of (DOS)
2022 · second_quarter · Health Issues
Issues regarding childrens health care coverage and access to care under Medicaid, CHIP, the Exchanges, and private insurance Issues related to implementation of aspects of childrens health coverage under Medicaid, CHIP, the Exchanges, and private insurance Issues regarding the implementation of the ACE Kids Act S.1544/H.R. 3089 - Accelerating Kids Access to Care Act H.R. 7076/S. 3864, the Supporting Childrens Mental Health Care Access Act H.R. 7249/S. 2686, the Anna Westin Legacy Act S. 3663 Kids Online Safety Act H.R. 7236 Strengthen Kids Mental Health Now Act S. 4472 Health Care Capacity for Pediatric Mental Health Act Issues regarding childrens health included in Build Back Better Act/reconciliation H.R. 4934, the Childrens Mental Health Infrastructure Act, H.R. 4944, the Helping Kids Cope Act, S.1902, the Behavioral Health Crisis Services Expansion Act, H.R. 5772, Brycen Gray and Ben Price COVID-19 Neurological Impact Act, H.R. 5703, the Post-Disaster Mental Health Response Act, Issues regarding childrens mental health, the national emergency in childrens mental health, and the Surgeon General Advisory on youth mental health. Issue regarding Medicaid supplemental payments HR. 3753/S. 1962 - Parity Implementation Act S.2762/H.R. 5131, the Pediatric Access to Critical Healthcare (PATCH) Act, and issues regarding pediatric health care infrastructure and capacity Issues regarding the importance of Medicaid to military and veteran families FY 2022 and FY 2023 Senate and House Labor-HHS appropriations provisions - Children's Hospitals Graduate Medical Education (CHGME) program funding Issues regarding Children's Hospitals Graduate Medical Education (CHGME) program reauthorization appropriations Issues related to 340B Drug Pricing Program, prescription drug pricing, drug shortages, and pharmaceutical supply chain, including H.R. 4390, the PROTECT 340B Act of 2021 Issues related to Provider Relief Funding Issues related to pediatric workforce Issues regarding the passage and implementation of COVID-19 relief packages, increased FMAP funding, and the impact of COVID-19 on childrens hospitals, the pediatric supply chain, and pediatric residency programs Issues regarding COVID-19 vaccination efforts for children Issues regarding surprise billing in health care H.R. 1397 - Telehealth Improvement for Kids Essential Services (TIKES) Act and broader telehealth policies Mental health funding provided in Consolidated Appropriations Act and ARPA Issues regarding the Public Health Emergency Issues regarding 340B drug program and other drug issues H.R. 3467, Improving Data Collection for Adverse Childhood Experiences Act H.R. 7691, Safety from Violence for Healthcare Employees (SAVE) Act H.R. 7255, the Garrett Lee Smith Memorial Reauthorization Act H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022 S.4170, The Mental Health Reform Reauthorization Act of 2022 Issues regarding infant formula shortage Issues regarding medical device shortages Issues regarding climate change HR 623, the Gabriella Miller Kids First Research Act 2.0
Client expense: $770,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2022 · second_quarter · Budget/Appropriations
Lobbying for increased appropriations for the African Development Bank H.R. 7691 - Additional Ukraine Supplemental Appropriations Act - support for African Development Bank
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
Issues related to gender-based violence; FY23 SFOPS Appropriations; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · second_quarter · Foreign Relations
Issues related to gender-based violence; FY23 SFOPS Appropriations; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · second_quarter · Foreign Relations
H.R.7077 - FY22 COVID Supplemental Appropriations Act H.R.7691 - FY22 Additional Ukraine Supplemental Appropriations Act H.R.8282 - House Department of State, Foreign Operations and Related Programs Appropriations for FY23 H.R.8239 - House Agriculture, Rural Development, FDA and Related Programs Appropriations for FY23 H.Res.136 - House Resolution on Importance of Diplomacy and Development to American Interests and National Security
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · second_quarter · Budget/Appropriations
H.R.7077 - FY22 COVID Supplemental Appropriations Act H.R.7691 - FY22 Additional Ukraine Supplemental Appropriations Act H.R.8282 - House Department of State, Foreign Operations and Related Programs Appropriations for FY23 H.R.8239 - House Agriculture, Rural Development, FDA and Related Programs Appropriations for FY23 H.Res.136 - House Resolution on Importance of Diplomacy and Development to American Interests and National Security
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
2022 · second_quarter · Aviation/Airlines/Airports
H.R. 5315, Drone Infrastructure Inspection Grant Act H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 S. 73, American Security Drone Act of 2021 S. 600, Drone Integration and Zoning Act Draft legislation related to criminal penalties and drones Draft legislation related to unmanned aircraft systems and R&D Draft legislation related to advancing unmanned aircraft systems and advanced air mobility Various issues relating to implementation of FAA Reauthorization Act of 2018 (P.L. 115-254); unmanned aerial systems flight restrictions near critical infrastructure facilities; general activity related to unmanned aerial systems; urban air mobility; potential Executive Order on unmanned aerial systems; supply chain and the defense industrial base; small business innovation research; Buy America provisions especially in infrastructure legislation;
Client expense: $15,800,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)
2022 · second_quarter · Foreign Relations
H.R. 3364 Countering Americas Adversaries Through Sanctions Act H.R. 4521, America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (America COMPETES) Act of 2022 H.R. 4616, Adjustable Interest Rate (LIBOR) Act 2021 H.R. 5544, To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to the products of Kazakhstan H.R. 7185, Federal Contracting for Peace and Security Act H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 S. 1260, United States Innovation and Competition Act of 2021 Draft legislation titled Making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2023, and for other purposes Various issues related to vaccine diplomacy; U.S. Chile Tax Treaty, Convention for the Avoidance of Double Taxation and the Prevention Of Fiscal Evasion With Respect to Taxes on Income and Capital; implementation of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; reform of the World Trade Organization; Canada's Digital Services Tax Act; Commercial Service Office in Bangladesh; Extraterritorial Application of Sec. 49 German Income Tax Act; supply chain and the defense industrial base; Buy America provisions especially in infrastructure legislation
Client expense: $15,800,000 · Firm income: Not reported
Government targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS)
2022 · second_quarter · Government Issues
H.R. 1/S. 1/S. 2093, For the People Act of 2021 H.R. 701, Unfunded Mandates Accountability and Transparency Act H.R. 3460/S. 1787, State Antitrust Enforcement Venue Act of 2021 H.R. 4737, Foreign Extortion Prevention Act H.R. 4773, Consumer Financial Protection Commission Act H.R. 5773/S. 2079, Stop Settlement Slush Funds Act of 2021 H.R. 6843, Building Civic Bridges Act H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 S. 742, Open and Responsive Government Act of 2021 S. 2428, False Claims Amendments Act of 2021 S. 2429, Administrative False Claims Act of 2021 Draft legislation titled Department of State, Foreign Operation and Related Programs Appropriations Act, 2023 Nomination of Grant Harris to be Assistant Secretary of Commerce for Industry and Analysis at the United States Department of Commerce Nomination of Chris Wilson to be Chief Intellectual Property Negotiator for the Office of the U.S. Trade Representative Nomination of Laurie Locascio to be Under Secretary of Commerce for Standards and Technology Nominations of Bradley Merrill Thompson, Beena Ammanath, Christina Montgomery, Paul Daugherty, and Dr. Swani Sivasubramanian to serve on the National Artificial Initiative Advisory Committee (NAIAC) Nomination of Gigi Sohn to be a Commissioner on the Federal Communications Commission Nomination of Kathryn Huff to be an Assistant Secretary of Energy Nomination of Alice Hill to serve as the Deputy Administrator for Resilience at the Federal Emergency Management Agency Nomination of Robert Gordon to be Assistant Secretary for Financial Resources at the Department of Health and Human Services Nomination of Alvaro Bedoya to be a Member of the Federal Trade Commission Nomination of Katherine Vidal to be Director of the U.S. Patent and Trademark Office (USPTO) Nomination of Mark Uyeda to be Commissioner of the U.S. Securities and Exchange Commission (SEC) Various issues relating to regulatory reform; application of Kristof Terryn to serve on the Department of Labor's Advisory Committee on Apprenticeship; COVID-19 vaccine requirements for federal contractors; False Claims Act and potential amendments related to materiality, and disclosure of third-party funding, U.S. Code cite. 31 USC 3729, et seq.; class action reform; antitrust; Corporate Enforcement Policy Issues Memorandum from the Deputy Attorney General, dated October 31, 2021; potential legislation dealing with state attorney general use of state AG use of outside contingency fee counsel; potential legislation on judicial review of administrative agency activities; government contractors during the coronavirus pandemic; use of the Defense Production Act (P.L. 81-774) during the coronavirus pandemic; implementation of the American Rescue Plan Act (P.L. 117-2); decisions of the Congressional Parliamentarians; reopening of Capitol Hill to visitors and the public; urging a rapid nomination of a new FAA Administrator; supply chain and the defense industrial base; small business innovation research; Buy America provisions especially in infrastructure legislation;
Client expense: $15,800,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, State, Dept of (DOS)
2022 · second_quarter · Defense
H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 Various issues relating to potential expansion of the Committee on Foreign Investment in the United States (CFIUS); Russian sovereign debt; amendments and potential amendments to the FY22 National Defense Authorization Act, related to potential debarment of federal contractors with certain Fair Labor Standards Act (FLSA) violations, to credit reporting, to printed circuit boards, and to perfluoroalkyl and polyfluoroalkyl substances (PFAS); potential provisions relating to the National Security Innovation and Industrial Base (NSIB) in the FY2023 National Defense Authorization Act; supply chain and the defense industrial base; small business innovation research; Buy America provisions especially in infrastructure legislation;
Client expense: $15,800,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), Natl Security Council (NSC), SENATE, State, Dept of (DOS)
2022 · second_quarter · Agriculture
H.R. 5376, Build Back Better Act, including provisions dealing with climate change as it relates to agriculture H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022, monitored for potential changes regarding the Federal Crop Insurance Program H.R. 8239, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023, monitored for funding levels and potential changes to administration of the Federal Crop Insurance Program S. 1251, Growing Climate Solutions Act Issues in support of preserving the Federal Crop Insurance Program, including in the 2018 Farm Bill and the upcoming 2022 reauthorization, agricultural appropriations, the budget, and the Standard Reinsurance Agreement. Regulatory reform improvements. Stimulus bills in relation to disaster payments to farmers. Monitor proposals impacting federal crop insurance programs.
Client expense: $470,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Risk Management Agency, SENATE
2022 · second_quarter · Foreign Relations
S.3522/H.R. 7611 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022; H.R. 6930 - Asset Seizure for Ukraine Reconstruction Act; H.R.7276 - Ukraine Invasion War Crimes Deterrence and Accountability Act; H.R. 6891 - Isolate Russian Government Officials Act of 2022; H.R. 8144 - Ukrainian Fighter Pilots Act, H. Res. 1205 - Recognizing Russian actions in Ukraine as a genocide.
Client expense: Not reported · Firm income: $20,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
2022 · second_quarter · Budget/Appropriations
HR 3807 "Restaurant Revitalization Fund Replenishment Act of 2021," all provisions. HR 7691 "Additional Ukraine Supplemental Appropriations Act, 2022," all provisions. HR 7790 "Emergency Supplemental Funding Bill to Address Baby Formula Shortage," all provisions. S 4008 "Small Business COVID Relief Act of 2022," all provisions. Issues pertaining to the inclusion of poison pill riders in appropriations. Issues pertaining to the inclusion of limiting amendments for rules issues under the Biden Administration.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
H.R. 8282 - State Department, Foreign Operations and Related Programs Appropriations Act, 2023 FY 2022 Budget Resolution H.R. 5305 - FY2022 Extending Funding and Emergency Assistance Act H.R. 5376 - Build Back Better Act H.R. 6119 - Further Extending Government Funding Act H.R. 8236 - Department of Defense Appropriations Act, 2023 S. 3023 - Department of Defense Appropriations Act, 2022 Unnumbered Senate bill - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H. R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 S. 3058 Homeland Security Appropriations Act, 2022 H.R. 8256 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R.2471 - Consolidated Appropriations Act, 2022 H.R.7691 - Additional Ukraine Supplemental Appropriations Act, 2022 Unnumbered Senate bill- State Department, Foreign Operations and Related Programs Act. 2023 Unnumbered Senate bill - Labor, Health and Human Services Appropriations Act, 2023.
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Foreign Relations
H.J.Res. 87: Directing the removal of United States Armed Forces from hostilities in the Republic of Yemen that have not been authorized by Congress; H.R. 7691: Additional Ukraine Supplemental Appropriations Act, 2022
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Foreign Relations
S. 3522 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 7691 - Additional Ukraine Supplemental Appropriations Act, 2022; H.R. 6930 - Asset Seizure for Ukraine Reconstruction Act; H.R. 7276 - Ukraine Invasion War Crimes Deterrence and Accountability Act; H.R. 6891 - Isolate Russian Government Officials Act of 2022; H.R. 7611 - Ukraine Democracy Defense Lend-Lease Act of 2022; H.R. 8144 - Ukrainian Fighter Pilots Act; H. Res. 1205 - Recognizing Russian actions in Ukraine as a genocide; H.R. 7429 - Russian Digital Asset Sanctions Compliance Act of 2022; and H.R. 8156 - Oligarch Assets for Ukrainian Victory Act of 2022; Issues related to humanitarian aid, sanctions, military aid, refugee processing.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office